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Supervising Professor: Jeffrey R. Stout, PhD. 
 
PURPOSE: The primary purpose of this study was to evaluate the effects of twenty-eight 
days of beta-alanine supplementation on markers of oxidative stress in men and women. 
METHODS: Twenty-five men (Age: 22.0 ± 3.3 yrs; maximal oxygen consumption 
(VO2max): 3.9 ± 0.5 l·min
-1
) and twenty-four women (Age: 21.7 ± 2.1 yrs; VO2max: 2.6 
± 0.3 l·min
-1
) volunteered to participate in this double-blind, placebo-controlled study and 
were randomly assigned to a beta-alanine (BA, 2 x 800 mg tablets, 3 x per day; 
CarnoSyn®, Natural Alternatives Inc, San Marcos, CA; n=  ) or placebo (PL, 2x 800 mg 
maltodextrin tablets, 3 x per day; n=) group for twenty-eight days of supplementation.  A 
maximal graded oxygen consumption test (VO2max) on a treadmill was performed to 
evaluate VO2max, time to exahustion (VO2TTE), ventilatory threshold (VT) and to 
establish peak velocity (PV).  Baseline blood draws were taken before, immediately post 
(IP), 2h post and 4h following a 40 min treadmill run at 70%PV to evaluate total 
antioxidant capacity (TAC), superoxide dismutase (SOD), 8-isoprostane (8ISO) and 
reduced gluthathione (GSH).  Heart rate and ratings of percieved exertion were recorded 
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during the 40 min run.    Separate four- [4 × 2 × 2 × 2; acute (base vs. IP vs. 2h vs. 4h) × 
chronic (pre- vs. post-) × treatment (placebo vs. beta-alanine) × sex (male vs. female)] 
and two- [2 × 2; time (pre-supplement vs. post-supplement) × treatment (placebo vs. 
beta-alanine)] way ANOVAS were used to identify and group by time interactions for 
oxidative stress markers and aerobic performance, respectively. RESULTS:  Both groups 
demonstrated significant improvements (p<0.05) in VO2max.  Percent change scores 
revealed a significant increase in VT for the male BA group.  Heart rate and ratings of 
perceived exertion values were significantly improved from pre- to post-supplementation 
for the BA group, while the PL group demonstrated non-significant negative changes.  
There was a significant (p<0.05) exercise induced oxidative effect on all markers.  The 
chronic effects of BA supplementation suggest there is an antioxidant effect on 8-
isoprostane and GSH, with no gender differences (p<0.05).  CONCLUSIONS:  The 
current findings support previous performance research, demonstrated the ergogenic 
benefit of BA on VT.  Additionally, an exercise-induced oxidative stress response, from a 
40 minute treadmill run, may be slightly attenuated following twenty-eight days of beta-
alanine supplementation for markers of lipid peroxidation and reduced glutathione, for 











The cause of exercise-induced oxidative stress is not completely understood.  
While moderate exercise is important for health and quality of life, intense, high volume 
physical activity can often times lead to injury, soreness and chronic fatigue.  Although 
these are multifaceted effects, an accumulation of free radicals may have some influence. 
As chemical species produced in all living cells, free radicals have the potential to react 
with several chemical species and play a role in several biological functions.  The 
majority of in vivo free radicals are capable of oxidizing a range of biological molecules 
including carbohydrates, amino acids, fatty acids and nucleotides [44].  Due to 
production and accumulation of free radicals within the body several antioxidant defenses 
have evolved, utilizing antioxidant enzymes such as superoxide dismutase (SOD), 
glutathione peroxidase (GPX), catalase and vitamins C and E to prevent deleterious 
effects and protect from substantial tissue damage.  SOD catalyzes the dismutation of 
superoxide to O2 and hydrogen peroxide (H2O2).  Additionally, GPX and reduced 
glutathione (GSH) reduce H2O2 to form oxidized glutathione (GSSG) and water [54].  In 
some circumstances, such as exercise, an overproduction of free radicals or a suppression 
of antioxidant defenses causes an imbalance, defined as oxidative stress [78, 94].  
Various mechanisms support an exercise induced increase in free radicals, which in turn 
confers a strong relationship between exercise and oxidative stress [2, 38].  Among free 
radicals, reactive oxygen species (ROS) are a species derived from oxygen and 
metabolism, an essential aspect of exercise [38].  Previous research has suggested the 
mitochondria as the major source of ROS [31, 76, 97], with the oxidation of hemoglobin 
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[24, 73] and increases in central temperature, catecholamines and lactic acid all leading to 
an influx of ROS [23, 24].  There is some evidence that ROS accumulation may have 
positive effects on the force of muscle contraction [85, 86], however, ROS are potentially 
harmful provoking inflammation and altered cell function. 
Of primary interest are the oxidative ramifications of ROS on lipid and protein 
oxidation and implications in muscular fatigue.  Lipid peroxidation is initiated by ROS 
altering membrane fluidity, permeability and increasing inflammation [84].  Oxidation of 
proteins can lead to structural and enzymatic alterations of amino acids increasing protein 
carbonyl groups [88] and free amino acids [65, 109].  More so, muscle-induced increases 
in ROS are heavily associated with fatigue during and immediately following exercise.  
Damage to the mitochondrial respiratory chain due to excess ROS, down regulates 
electron transfer and ATP formation, rendering aerobic pathways less efficient.  This 
phenomenon leads to a greater reliance on anaerobic metabolism resulting in a large 
amount of metabolic by-products (inorganic phosphate (Pi), and lactate) [87].  
Furthermore, intracellular calcium increases, inactivation enzymes decrease and the 
potassium influx system are all hindered by excess ROS, resulting in muscular fatigue 
and altering muscle contraction [21, 67].   
 The endogenous and nutritional antioxidant system plays an important role in 
managing the balance of antioxidant enzymes to the production of free radicals in order 
to minimize free radical damage and reduce oxidative stress.  Several exogenous 
antioxidants have been studied in relation to oxidative stress.  One particular supplement 
has gained recent popularity among researchers and athletic community as an agent to 
delay fatigue, and has surfaced as a possible antioxidant. Carnosine (β-alanyl-L-histidine) 
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is a cytoplasmic dipeptide found in high concentrations in both vertebrate and non-
vertebrate skeletal muscle. Carnosine is synthesized in skeletal muscle from l-histidine 
and beta-alanine amino acids in a reaction catalyzed by carnosine synthetase.  
Additionally, although skeletal muscle is able to synthesize carnosine, these cells cannot 
uptake carnosine from the bloodstream [9].  More so, skeletal muscle is unable to 
produce either L-histidine (an essential amino acid) or beta-alanine, whose production is 
confined to the liver [70].  Therefore, it is recognized that endogenous synthesis of 
carnosine is primarily dependent upon the uptake of beta-alanine and L-histidine by the 
muscle.    Furthermore, plasma concentration and the affinity of carnosine synthetase 
(Km ~16.8 µM) of L-histidine is greater than plasma concentrations and synthetase 
affinity of beta-alanine (~1-2.3 µM).  Consequently, the rate-limiting point of 
endogenous synthesis of carnosine in humans is the availability of beta-alanine within the 
muscle.  Additionally, beta-alanine supplementation has been shown to significantly 
increase the intramuscular carnosine content [46, 47]. 
Carnosine and its related dipeptides can be hydrolyzed by at least two types of 
dipeptidases.  Serum carnosinase is a secreted enzyme and is highly present and active in 
human plasma [6].  With a large concentration in the plasma, carnosine is virtual absent 
in the post-absorptive state due to its rapid and complete hydrolysis [6].  The absence of 
carnosinase from skeletal muscle tissue and other types of tissues was demonstrated by 
Severin et al. [95].  If carnosinases are absent from human muscle, then carnosine is 
hypothesized to remain stable within skeletal muscle and display a slow washout profile.  
In support, it has been shown that carnosine levels are typically highest in type II muscle 
fibers but still found in type I slow twitch fibers [45, 46].  Carnosine is available from 
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two sources; it can be readily extracted from natural sources or synthesized chemically by 
incorporating beta-alanine and histidine in the presence of carnosine synthase.  The 
natural histidine-containing dipeptides, carnosine and anserine, are powerful antioxidants 
that are known to protect cell membranes and other cell structures. The antioxidant effect 
of carnosine has been demonstrated at both the cell and tissue levels with the ability to 
suppress peroxidation induced both enzymatically and non-enzymatically, and 
eliminating the products of free radical reactions [19, 20].  A modest body of literature 
supports the role of carnosine as an agent to delay fatigue [47, 100, 102, 106, 112].  A 
number of explanations have been proposed for such an effect, such as an increase in the 
efficiency of the electromechanical coupling [17], stimulation of ATPase activity of 
contractile proteins and activation of ATP producing enzymes [15, 82] and may also be 
related to its proposed antioxidant capacity.  In general, this compound is reported to 
possess antioxidant, buffering, immune-enhancing and neurotransmitter actions.  
Carnosine is also known to be an antioxidant that is capable of preventing the 
accumulation of oxidized products derived from lipid components of biological 
membranes [27, 28].  Furthermore, carnosine has been shown to possess superoxide 
dismutase activity and appears to regulate lipoxygenase activity [16, 27].  The 
combination of histidine-containing compounds, such as carnosine, at near physiological 
concentrations, have resulted in synergistic antioxidant activity [63].  Several models to 
examine the antioxidant activity of histidine containing dipeptides have been devised 
consisting of determination of the accumulation of reactive oxygen species (ROS), lipid 
peroxidation, protein oxidation, and total antioxidant capacity via various antioxidant 
enzymes.  Although there is no evidence that carnosine alters neuronal excitability of 
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modulation of synaptic transmission, as least one function of carnosine may be to prevent 
damage to the cell from production of reactive oxygen species [16, 20].  
Boldyrev and colleagues were the first to ascertain the membrane-protecting 
properties of carnosine [17, 18].  Specifically, in a system containing a combination of 
carnosine and anserine with sarcoplasmic reticulum membranes, demonstrating that the 
dipeptides decreased membrane lipid oxidation rates as determined by TBARS [18].  The 
hydrophilic structure of carnosine plays a large role in its protective characteristic within 
the cytosol, where a majority of lipid oxidation catalysts and free radicals are found.  
Carnosine has been shown to exhibit 53% protection against lipid oxidation at a 
concentration of 10 mM [91].  The antioxidant mechanism of carnosine has been 
postulated to be due to metal chelation or free radical scavenging [40].  Furthermore, 
recent evidence from electronic paramagnetic resonance studies has shown that carnosine 
may inactivate hydroxyl radicals generated by iron and H2O2 [22]. Carbon-centered 
radicals of carnosine and homocarnosine were detected in the presence of hydroxyl 
radicals, demonstrating that histidine-containing dipeptides are capable of scavenging 
hydroxyl radicals.  Furthermore, the interaction of carnosine and anserine with singlet 
oxygen was investigated by a direct luminescent method and both compounds were found 
to efficiently quench singlet oxygen at rate constants ranging from 2-4 x 10
7 
M/s [35].  
Ergov et al. [35] suggested that the quenching of the singlet oxygen was primarily 
attributed to the imidazole group of carnosine and anserine.  Carcinine and carnosine 
have also been shown to be good scavengers of hydroxyl  radicals, as detected by iron-
dependent radical damage to the sugar deoxyribose suggesting that carnosine and 
carcinine are able to scavenge free radicals or donate hydrogen ions [7].   Boldyrev and 
6 
 
colleagues (1997) have suggested that the antioxidant protective effects of carnosine can 
be attributed to its binding affinity to reactive species, such as hydroxyl radicals and ROS 
and therefore preventing compounded damage [20]. 
 While carnosine has demonstrated positive effects on oxidative stress biomarkers, 
all of the current studies have been conducted in vitro and in animal models.  
Additionally, research suggests that carnosine is not stable within the blood.  Therefore, 
further research is warranted on the ability of carnosine to sequester free radicals in vivo 
and elicit the effect of its constituent, beta-alanine. 
Purpose 
1.   The primary purpose of this study was to evaluate the effects of twenty-eight days 
of beta-alanine supplementation on markers of oxidative stress. 
2.   A secondary purpose was to investigate the effects of beta-alanine 
supplementation on measures of aerobic performance, maximal aerobic 
consumptions (VO2max), time to exhaustion during VO2max (VO2TTE), and 
ventilatory threshold (VT). 
3.  A third purpose was to evaluate the effects of a 40 minute run, at 70%VO2max, as 
a method to induce oxidative stress. 
4.  Finally, a fourth purpose of this study was to evaluate the sex differences in 
response to an acute 40-minute running bout of induced oxidative stress. 
Hypotheses 
1. It was hypothesized that an acute bout of aerobic exercise would induce oxidative 
stress.  Oxidative stress markers would be altered from rest to immediately post 
(IP), up to two hours post (2h), and returning baseline by four hours (4h).  
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Specifically, superoxide dismutase (SOD) would be reduced immediately post 
exercise and increase above baseline values during recovery.  Glutathione (GSH) 
would be reduced immediately post exercise, reaching its lowest values at 2h post.  
Lipid peroxidation, measured by 8-isoprostane, would demonstrate and increase 
IP and return to baseline by 2h.  Total antioxidant capacity would increase IP. 
2. It was hypothesized that twenty-eight days of beta-alanine supplementation would 
reduce oxidative stress markers.  The reduction in SOD and GSH would be 
blunted compared to baseline levels.  Both markers would increase during 
recovery to a lesser degree than during baseline evaluations.  The increases in 8-
isoprostane, total antioxidant capacity would be blunted with supplementation.  
 
3. It was hypothesized that the twenty-eight days of beta-alanine supplementation 
would have no influence on VO2max, while there would be an ergogenic effect on 
VT and VO2TTE. 
4. It was hypothesized that a 40-minute run at 70%VO2max would be sufficient to 
induce an oxidative stress response. 
5. It was hypothesized that the acute and chronic oxidative stress responses would 
not be different between genders. 
Operational Definitions 
Maximal Oxygen Consumption – (VO2max) The maximum rate at which oxygen can be 
taken up and used by the body during exercise.   
Supplement Loading Phase – The loading phase consistend of supplementing with 1600 
mg beta-alanine three times daily (4.8 g) for twenty-eight days. 
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Oxidative Stress-Is a condition in which the balance between pro-oxidant (free radicals) 
production and their amelioration via the antioxidant defense system 
becomes skewed in favor of free radical expression leading to lipid 
and protein peroxidation and DNA damage. 
Abbreviations 
VO2max- maximal oxygen consumption 
SOD- superoxide dismutase 
GSH- reduced glutathione 
8-Isoprostane- measure of lipid peroxidation from the breakdown of arachidonic acid. 
TAC- total antioxidant capacity 
Delimitations 
Twenty-six men and twenty-eight women between the ages of 18 and 35 years were 
recruited for this study.  All participants completed a health history questionnaire and a 
written statement of informed consent prior to any testing.  To be eligible for inclusion in 
this study, participants were determined to be moderately physically active, which was 
defined by 3-7 days per week of structured and/or recreational exercise, but they could 
not be untrained (1-2 hours of exercise per week) or competitive athletes.  Volunteers 
from this study were free from any current musculoskeletal injuries and did not sustain 
any injuries within the four weeks prior to baseline testing.  The participants were 
encouraged to remain involved in their current exercise training regime, but they were 
unable to begin any new endurance or resistance training program.  Subjects could not 
have taken (within three months) or begin taking any nutrition supplements.  A multi-
vitamin was acceptable, but had to be recorded ahead of time and maintained throughout 
the duration of the study.  A list of such supplements included, but were not limited to the 
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following: creatine, beta-alanine, branched chain amino acids, vitamin E, vitamin C, and 
weight loss pills. Volunteers were instructed to refrain from caffeine, alcohol, analegesics 
(asprin, acetaminophen, non-steroidal anti-inflammatories, and glucoceroticoids) and 
cigarettes during pre- and post-testing weeks.   
Assumptions 
Theoretical Assumptions 
1.  Subjects accurately answered the health history questionnaire. 
2.  All subjects gave maximal effort when performing VO2max tests. 
3.  Participants maintained their current training routine throughout the duration of 
the study. 
4.  Absention from caffeine, alcohol and analegesics (asprin, acetaminophen, non-
steroidal anti-inflammatories, and glucoceroticoids) on all testing days during pre- 
and post-trials. 
5.  Participants consumed a similar diet prior to the oxidative stress run for the pre- 
and post-testing sessions. 
6.  Subjects were compliant with the supplementation protocol. 
7.  Twenty-eight days of beta-alanine supplementation significantly augmented 
muscle carnosine levels. 
8.  The subject’s knowledge of their assigned supplementation group did not 




1.  The population from which the samples are drawn was normally distributed. 
2.  The sample was randomly selected and the treatment order was randomly placed. 
3.  The data met the assumption of sphericity.  Sphericity requires that the repeated 
measures data demonstrate both homogeneity of variance and homogeneity of 
covariance. 
Limitations 
1.  Subjects were recruited as students from several departmental courses and 
responded to advertisements located within and around the Huston Huffman 
Center; therefore, the process of subject selection may not have been truly 
random.  In addition, the sample was made up of volunteers, therefore not 
meeting the underlying assumption of random selection. 
2.  Due to time constraints of the supplementation protocol, repeated blood draws, 
and intensity of the testing session, participant withdrawl was inevitable. 
3.  Daily dietary fluctuations in endogenous antioxidant consumption may have 
occured, influencing the oxidative stress responses.  A decrease in immune 





REVIEW OF LITERATURE 
 
Oxidative stress markers and timing of sampling 
Khassaf, Child, McArdle, Brodie, Esanu, Malcolm, Jackson, 2001 [59] 
Time course of responses of human skeletal muscle to oxidative stress induced by 
nondamaging exercise. 
 
The primary aim of this study was to evaluate the time course response of common 
antioxidant enzymes in human skeletal muscle after a period of exhaustive, nondamaging 
aerobic exercise.  Seven male participants completed an incremental test to exhaustion on 
a cycle-ergometer (Monark 864), using a single leg, increasing 35 W every four minutes.  
Subsequently, participants performed a single-leg constant-load ride at 70% of VO2peak 
for 45-min using the opposite leg from the previous test.  Muscle biopsies using the 
Bergstrom-needle were taken from the vastus lateralis of the exercised leg at seven days 
prior to the exercise protocol, and at one, two, three and six days after.  Muscle samples 
were homogenized in phosphate buffer, pH 7.0, and analyzed for catalase activity by the 
kinetic decomposition of hydrogen peroxide spectrophotmetrically.  Total superoxide 
dismutase (SOD) activity was measured using a SOD-525 kit (R & D Systems Europe).  
HSPs were also analyzed using monoclonal antibodies.  Peripheral blood samples were 
also obtained from the subjects before the muscle biopsy at seven days before exercise 
and at one and three days postexercise and analyzed for total creatine kinase activity.  
Muscle superoxide dismutase activity increased to a peak at three days post-exercise, 
with no change in muscle catalase activities.  Muscle content of HSP60 and HSP70 
increased by 190% and 3,100% of preexercise values, respectively.  Ultimately, these 
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results indicate that human skeletal muscle responds to a single bout of nondamaging 
exercise by increasing superoxide dismutase activity and suggests an upregulation of 
HSP content of human muscle after a submaximal exercise bout. 
Michalidis, Jamurtas, Nikolaidis, Fatouros, Koutedakis, Papassotiriou, Kouretas, 2007  
[72] 
Sampling time is crucial for measurement of aerobic exercise-induced oxidative 
stress 
 
The purpose of this study was to thoroughly investigate the time-course changes of 
several commonly used markers of oxidative stress by performing serial measurements 
during a 24-h period after an acute bout of cardiovascular exercise.  A batter of oxidative 
stress markers were used due to the lack of research on just one single biomarker to 
reliably describe oxidative damage.  Eleven untrained men (age, 23 ± 6 yr, ht: 175 ± 3 
cm, wt: 75 ± 5 kg; %BF: 14 ± 3%, VO2max: 47 ± 6 mL/kg/min) performed two trials in 
a random, counterbalanced design.  An initial VO2max measurement was conducted to 
assess the experimental intensities.  Seven to 14 days following the VO2 test, subjects 
either rested (control trial) or exercised on a treadmill at 70-75% of their VO2max for 45 
minutes (experimental trial).  During the experimental trial, the intensity was increased to 
90% VO2max after 45 minutes and exercise was terminated at exhaustion.  Water was 
given ad libitum, heart rate, RPE were measured throughout and food consumption was 
kept constant with a banana given during the first hour of the post-exercise, followed by 
standard meals at lunch and dinner.  Blood samples were drawn via catheter at rest, 
immediately after exercise and at 0.5, 1, 2, 3, 4, 5, 6, 8, 10, and 24h post.  Directly after 
taking the blood samples, 5% trichloroacetic acid (TCA) was added to whole blood 
collected in EDTA tubes for reduced glutathione (GSH) analysis.  For oxidized 
glutathione (GSSG) analysis, 5% TCA and 2-vinyl pyridine were added to whole blood 
13 
 
collected in EDTA tubes.  The whole-blood samples were centrifuged at 4000g for 10 
min at 4ºC.  Two hundred µL of the supernatant were dispensed in tubes and mixed with 
60 µL of 5% TCA and centrifuged again at 28,000g for 5 min at 4ºC, and the clear 
supernatants were collected and stored at -30ºC until analysis.  Another portion of the 
blood was collected in plain tubes, left on ice for 20 min to clot, and centrifuged at 1500g 
for 10 min at 4ºC for serum separation.  Serum was transferred in Eppendorf tubes and 
used for the determination of thiobarbituric acid reactive substances (TBARS), protein 
carbonyls, catalase and total antioxidant capacity (TAC).  Samples were stored in aliquots 
and -30ºC and were thawed before analysis.  For GSH, 20 µL of whole blood was treated 
and incubated in the dark for 45 min and the absorbance was read at 412 nm.  GSSG was 
assayed by treating 260 µL of whole blood with TCA, NaOH, 2-vinyl pyridine and 
incubated for 2h at room temp, followed by the addition of TCA, sodium phosphate, 
NADPH, DTNB, glutathione reductase and then read for absorbance at 412 nm for 3 min.  
For TBARS, 100 µL of serum was mixed with TCA and Tris-HCL, incubated for 10 
minutes, followed by the addition of Na2SO4 and 55mM thiobarbitruic acid solution and 
incubated at 95ºC for 45 min.  The samples were collected on ice for 5 min, centrifuged 
at 15,000g for 3 min and the absorbance of the supernatant was read at 539 nm.  To 
measure protein carbonyls, 50 µL of TCA was added to 50 µL of serum and incubated in 
an ice bath for 15 min and centrifuged at 15,000g for 5 min at 4ºC.  The supernatant was 
discarded and 500 µL of 2,4-dinitrophenylhydrazine was added to the pellet and 
incubated in the dark for 1h with intermittent vortexing every 15 min, followed by a 
washing step repeated 3 times, and then read at an absorbance of 375 nm.  For TAC, 480 
µL of 10 mM sodium potassium phosphate and 500 µL of 0.1 mM 2,2-diphenyl-1-
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picrylhydrazyl free radical were added to 20 µL of serum, and the samples were 
incubated in the dark for 30 min at room temp.  Samples were centrifuged for 3 min at 
20,000g and the absorbance was read at 520 nm.  Macronutrient and antioxidant intake 
was controlled by having participants consume the same diet before both trials.  The time 
to lowest concentration after exercise was 1.7 ± 0.7h for GSH/GSSG, and the time to 
highest concentration after exercise was 1.2 ± 0.6h for TBARS, 4.4 ± 0.5h for protein 
carbonyls, 0.5 ± 0.4h for catalase, and 2.2 ± 0.9 for TAC.  The greatest change after 
exercise was -74 ± 9% for GSH/GSSG, 129 ± 29% for TBARS, 135 ± 53% for protein 
carbonyls, 51 ± 16% for catalase, and 24 ± 10% for TAC.  In conclusion, there is no best 
time point applying to all markers for collecting blood samples after aerobic exercise.  
The optimum postexercise time points for blood collection in untrained individuals are 
immediately after exercise for catalase, 1h for TBARS, 2h for TAC, GSH, and GSSG, 
and 4h after exercise for protein carbonyls. 
 
Effects of acute exercise on oxidative stress. 
Schneider, Barp, Ribeiro, Bello-Klein, Oliveira, 2005  [92] 
Oxidative stress after three different intensities of running 
 
The purpose of study was to examine the effect of three exercise intensitites based on 
ventilator thresholds on blood enzyme activities (superoxide dismutase, catalase, 
glutathione peroxidase), antioxidant capacity (TRAP), and lipid peroxidation (LPO).  
Participants were assigned to groups based on training status with triathletes (T; n=8) and 
physical education students (UT; n=9).  Each subject underwent four exercise test on a 
treadmill with the first test being an incremental test to exhaustion to determine VO2max, 





increasing by 0.5 5 km·h
-1
 every 20 s (T) or every 30 s (UT) .  The subsequent three 
exercise tests were performed in random order and were designed so that the subjects 
could maintain a steady state VO2 corresponding to 10% below AeT (VT1- low 
intensity), 10% below AnT (VT2-intermediate intensity) and the average between AnT 
and VO2max (AnM-high intensity) for 30 minutes, respectively.  Blood samples were 
taken within 15 minutes before exercise and immediately after exercise by venous 
puncture.  Blood samples were drawn into a tube with 100 µL EDTA 10% for 
hemoglobin (Hb), lipid peroxidation, TRAP, SOD, catalase (CAT), and CPx analysis.  
After collection, samples were centrifuged for 5 min at 1,000g.  Plasma was stored at -70 
ºC for further analysis of TRAP.  Erythrocytes were washed and centrifuged three times 
with the same volume of saline solution.  Then 75 µL of erythrocytes were diluted in 500 
µL of saline solution for LPO and Hb analysis.  Remaining erythrocytes were prepared 
and stored at -70 ºC for protein and antioxidant enzyme analysis.  SOD activity was 
determined by the inhibition rate of pyrogallol auto-oxidation at 420 nm from a standard 
curve of commercially available SOD kit.  Glutathione peroxidase activity was measured 
by following NADPH oxidation at 340 nm.  Catalase activity was measured by following 
the decrease in absorption at 240 nm.  Lipid peroxidation was measured in erhthyrocytes 
using 400 mmol·L
-1
 tert butyl hydroperoxide initiated chemoluminescence and then light 
emission was measured using a tritium channel.  Total antioxidant capacity was measured 
in plasma using 320 µmol·L
-1
 trolox as standard antioxidant.  In plasma, LPO decreased 
from 3589 ± 193 to 3274 ± 223 cps·mg Hb
-1
 and TRAP increased from 340 ± 45 to 384 ± 
57 µmol·L
-1
 trolox after high intensity exercise in the Trained group.  GPx activity 
increased in the T group only after exercise at moderate and high intensities.  Superoxide 
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dismutase activity increased after exercise at low (8.35 ± 0.85 to 9.23 ± 1.03 U SOD·mg 
protein
-1
) and moderate (8.89 ± 0.98 to 10.44 ± 0.86 U SOD·mg protein
-1
) intensity in 
UT.  There were no changes in catalase activity.  In summary, the data indicate that total 
antioxidant capacity was increased after exercise, and that GPx activity was higher in 
triathletes than in untrained subjects.  CAT activity showed no changes, indicated that the 
ROS involved in this model were scavenged by GPs.  The authors also speculate that 
these models of exercise could raise plasma uric acid, vitamins, and other anti-oxidants, 
and therefore increasing serum antioxidant capacity and reduce exercise-induced 
oxidative stress in T individuals.  
Alessio, Hagerman, Fulkerson, Ambrose, Rice, Wiley, 2000  [3]   
Generation of reactive oxygen species after exhaustive aerobic and isometric 
exercise 
 
The purpose of this study was to compare biomarkers of oxidative stress: lipid 
peroxidation, protein oxidation, and total antioxidants in blood after exhaustive aerobic 
(AE) and nonaerobic isometric exercise (IE).  Twelve men and women completed an 
initial 2-day diet recall followed by a maximal AE test to exhaustion on a treadmill.  
Immediately pre, immediately post, and 1 h post exercise, a blood sample was drawn 
from an antecubital vein into an evacuated tube, and centrifuged immediately at 4ºC.  
Serum was separated and immediately frozen at -80ºC.  Blood levels of malondialdehyde 
equivalents (MDA), lipid hydroperoxides (LH), protein oxidation, antioxidant activity, 
and lactate were measured.  One week later, subjects performed a maximum nonaerobic 
(IE) test using a hand grip dynamometer, by performing and MVC with the dominant 
hand while in the sitting position.  Blood samples were drawn in the same fashion to the 
AE test.  Venous blood was collected.  Samples for lactate concentration (0.050 mL) 
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were immediately placed in 6% perchloric acid.  Blood was centrifuged at 3000 rpm at 
4ºC, serum was separated from red blood cells and stored.  LH were measured with 
chemicals purchased from Cayman Chemical.  Absorbance was measured at 500 nm.  
Lipid peroxidation by-products (MDA) were measured using chemicals from 
Calbiochem.  Absorbance was measured at 586 nm.  Protein carbonyls were precipitated 
from 50 µL aliquots of plasma with trichloroacetic acid and reacted for 60 min at room 
temp.  The derivitized proteins were isolated by precipitation with tricholoacetic acid and 
washed extensively.  Absorbances were recorded at 364 nm.  Antioxidant activity was 
indicated by the oxygen radical absorbance capacity (ORAC) in plasma. The ORAC 
assay is an inhibition method in which a sample of serum is added to a free radical-
generating system, using 10 µL of plasma.  VO2 increased 14-fold with AE compared 
with 2-fold with IE.  Protein carbonyls increased 67% pre- to immediately and 1 h post-
AE, and 12% pre- to immediately post-IE and returned to baseline 1 h post-IE.  TBARS 
did no increase significantly with either treatment.  LH increased 36% above rest during 
IE compared with 24% during AE.  ORAC increased 25% pre- to post-AE, compared 
with 9% pre- to post-IE.  In the current study, lipids were more likely to undergo 
peroxidation during exhaustive IE and proteins were more likely to be oxidized and form 
carbonyls during exhaustive AE.  Compared with IE, AE was associated with an 
approximately 2.5-fold increase in peroxyl radical quenching activity.  The stimulus for 
pro-oxidant and antioxidant activity must differ between AE and IE due to the different 
metabolic demands, although a mechanistic basis for this distinction is not clear. 
 
Lovlin, Cottle, Pyke, Kavanagh, Belcastro, 1987  [66] 




The stress of exercise, by causing substrate depletion and modification of the 
NADH/NADPH ratio by effecting lactate production, uptake and removal, may also 
directly affect free radical generation and lipid peroxidation.  Therefore the aim of the 
present study was to evaluate a possible relationship between exercise intensity, lactate 
metabolism and lipid peroxidation.  Six male subjects completed five exercise sessions. 
Two initial maximal oxygen consumption tests were conducted on a Monark ergometer, 
beginning with a 5 min warm-up at 88 W, then increased by 30 W each minute until 
exhaustion.  In the remaining three exercise tests, the subjects first rested for 15 minutes 
on the ergometer, with a blood sample drawn after 7 min.  The subjects then exercised at 
40% VO2max for 5 min and rested for 5 min.  This was immediately followed by 5 min 
of exercise at 70% VO2max and 5 min of rest. The subjects then completed the 
intermittent exercise regime by pedaling to voluntary exhaustion at an increase load (30 
W each minute).  Blood samples were drawn into 7 ml heparinized vacutainers at the 
midpoint of the rest periods and after voluntary exhaustion.  The samples were 
immediately placed on ice and help until completion of the exercise test when they were 
centrifuged to separate plasma.  The plasma was stored in the refrigerator and analyzed 
the next day.  Three plasma aliquots (300 µL) were analyzed for evidence of lipid 
peroxidation by adding the plasma to distilled water before addition of HCL TBA reagent 
solution.  The samples were put in a hot bath at 95 ºC for 8 min, centrifuged for 10 min 
and the optical density was measured at 535 nm.  Lactate concentrations were determined 
enzymatically by converting lactate to pyruvate in the presence of lactate dehydrogenase 
(LDH) and NAD
+
.  All samples were analyzed in triplicate after adding 0.1 ml of the 
deproteinized samples to 2.9 ml of the reagent solution and incubated.  Samples were 
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read at 340 nm.  The same procedure was used for determination of MDA, based on 
MDA standards.  Maximal exercise to exhaustion resulted in a 26% increase in plasma 
lipid peroxides.  Short periods of intermittent exercise, with varied intensities, indicated a 
correlation between lactate and MDA.  Blood lactate concentrations increased throughout 
this exercise regimen.  A significant decrease (10.3%) in plasma MDA occurred at 40% 
VO2max.  At 70% VO2max plasma MDA was still below resting values.  At exhaustion, 
plasma MDA and lactate were significantly greater then at rest.  Lovin and colleagues 
suggest, based on their findings, that exhaustive maximal exercise induces free radical 
generation while short periods of submaximal exercise (<70% VO2) may inhibit free 
radical generation and lipid peroxidation.  
 
The influence of exogenous antioxidants on oxidative stress 
Bloomer, Goldfarb, Mckenzie, 2006  [12] 
Oxidative stress response to aerobic exercise: comparison of antioxidant 
supplements 
 
The primary aim of this investigation was to compare the effects of vitamin C + E (the 
most examined antioxidants studied in relation to exercise) and an ecapsulated fruit and 
vegetable juice powder concentrate on the oxidative stress response to acute aerobic 
exercise.  Aerobically trained men (n=25) and women (n=23) were assigned to one of 
three treatments: 400 IU of vitamin E + 1g of vitamin C (V; n=15), a fruit and vegetable 
juice powder concentrate (FV; n=16) or a placebo (P; n=17).  All participants completed 
a maximal graded exercise test at 0% grade at a self-selected pace.  The grade was 
increased every 2 min while the speed was kept constant, with subjects reaching 
exhaustion by 8-12 minutes.  The VO2max data were used to calculate the workload for 
the submaximal exercise bouts and to categorize fitness levels.  Subjects ran for 30 min at 
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80% VO2max before, after two weeks of supplementation, and after a one-week washout 
period.  Plasma proteins, protein carbonyls, malondialdehyde, and vitamin E were 
determined from blood collected via vacutainer and immediately centrifuged at 3000 rpm 
for 15 min at 4ºC and then stored at -80ºC until analyzed.  An additional 5 mL of blood 
was collected into serum collection vacutainers for analysis of 8-OHdG.  Blood was 
allowed to clot at room tem and then separated for serum and stored for later analysis. All 
assay procedures were performed in duplicate.  Plasma protein was determined 
comparing samples against known standards and plasma samples were also used for the 
measurement of malondialdehyde.  Measurement of 8-OHdG was performed using an 
ELISA from Genox corp.  Vitamin C analysis was performed immediately on plasma by 
adding it to 5% TCA, 85% orthophosphoric acid and α,α’ dipyridyl and were read at 525 
nm and compared against a standard curve.  Plasma vitamin E was determined by HPLC 
at 290-nm wavelength.  The V treatment increased plasma vitamin C and E after two 
weeks of supplementation, with no change in the FV or P.  Postexercise PC values were 
elevated for all treatments after all exercise bouts.  Both V and FV attendated the 
exercise-induced increase in PC two weeks of supplementation (V=21%, FV=17%), and 
after the 1-week washout (V=13%, FV=6%) compared with P, and no differences 
between V and FV.  MDA was unaffected by exercise and treatment. 8-OHdG was 
significantly lower for V than for FV and P.  The authors suggest that V and FV 
supplementation for 2wk can attenuate the rise in protein carbonyls after 30 min of 






Goldfarb, McKenzie, Bloomer, 2007  [41] 
Gender comparisons of exercise-induced oxidative stress: influence of antioxidant 
supplementation 
 
The purposes of this investigation were (i) to ascertain if gender has an influence on 
exercise-induced oxidative stress using a moderate-intensity exercise with equal relative 
exercise intensity, and (ii) to ascertain if gender has an effect on antioxidant 
supplementation on blood indices of oxidative stress under controlled conditions.  
Twenty-five men and 23 women underwent a graded VO2max test on a treadmill.  After a 
five minute warm up, subjects ran at a self-selected pace at 0% grade for two minutes 
with an increase in grade of 2% every two minutes.  Subjects were randomly assigned to 
one of three treatments: placebo (P), antioxidant (A: 400 IU vitamin E + 1 g vitamin C), 
or a fruit and vegetable powder (FV).  All subjects completed three exercise bouts at 80% 
VO2max for 30 minutes, before and after two weeks of treatment and again after a one-
week washout period and were allowed to consume water ad libitum during the exercise.  
Blood samples were obtained before and immediately after each exercise bout form an 
antecubital vein.  About 10 mL of blood was obtained by vacutainer at all collections.  
Samples were immediately processed for glutathione and vitamin C.  Plasma was 
obtained and later analyzed for protein carbonyls (PC), vitamine E, and malondialdehyde 
(MDA).  Serum was obtained and stored in separate microtubes and analyzed for 8-
hydroxydeoxyguanosine (8-OHdG).  Whole blood was immediately processed for 
glutathione.  Blood was immediately treated with 10% 5-sulfosalicylic acid containing 1 
mmol/L bathophenanthrolinedisulfonic acid mixed and centrifuged at10,000 r/min for 15 
min at 4ºC.  The supernatants were stored at -80ºC and later determined for total 
glutathione (TGSH) and oxidized glutathione (GSSG).  TGSH and GSSG were analyzed 
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using 5,5’-dithiobis-2-nitrobenzoic acid and measured at 412 nm using a 
spectrophotometer (Shimadzu UV-1601).  GSH was computed by subtracting 2 x the 
value obtained for GSSG from TGSH (GSH=TGSH-(GSSG)).  Plasma protein was 
determined by comparison to a known standard and was run through columns and the 
effluent monitored spectrophotometrically.  MDA was measured using a colorimetric 
method and 8-OHdG was performed using an enzyme-linked immunosorbent assay from 
Genox Corp.  Before supplementation, women had higher resting reduced glutathione, 
total glutathione, and plasma vitamin E compared with men.  With both A and FV 
supplementations, plasma vitamin E gender differences disappeared.  Protein carbonyls, 
oxidized glutathione and malondialdehyde all increased similarly for both men and 
women in response to exercise.  Both A and FV attenuated the reduced glutathione 
decrease and the oxidized glutathione and protein carbonyls increase compared with P, 
with no gender differences.  8-OHdG was lower with treatment A compared with FV and 
P only for men.  Plasma vitamin C increased 39% (A) and 21% (FV) compared with P.  
In conclusion, this study indicates subtle differences in men and women at rest and prior 
to antioxidant supplementation with several oxidative stress markers.  This study 
demonstrates that young men and women given similar relative intensity and duration of 
exercise will demonstrate comparable alterations in blood markers of oxidative stress.  
Despite slightly different antioxidant protection prior to supplementation, men and 
women given a similar antioxidant treatment for two weeks can enhance their antioxidant 






Watson, Callister, Taylor, Sibbritt, Macdonald-wicks, Garg, 2005  [110] 
Antioxidant restriction and oxidative stress in short-duration exhaustive exercise 
 
Watson and colleagues primary purpose was to determine the effects of dietary 
antioxidant restriction on oxidative stress (as measured by F2-isoprostane), antioxidant 
defenses (as measured by TAC, uric acid, vitamins E, C and β-carotene, and serum 
glutathione), and exercise performance in athletes.  Seventeen healthy, well-trained male 
endurance running athletes performed an initial VO2max incremental test to exhaustion 
starting at 10 km·h
-1
 with 0% gradient.  Speed was increased 2 km·h
-1
 every two minutes 
until the subject could not run any faster; the gradient was then increased by 2% each 
minute until the fatigue.  Subsequently, participants underwent two separate exercise 
tests, running 30 min at 60% VO2max, followed by an incremental running test to 
exhaustion immediately following, increasing the speed by 2 km·h
-1
 every two minutes to 
top running speed.  Before the initial exercise tests, participants followed their habitual 
(high) antioxidant (H-AO) diets.  Then they followed a two-week restricted-antioxidant 
(R-AO) diet before the second exercise test.  Four 20-mL blood samples were collected at 
rest, after 30 minutes of submaximal exercise, immediately after high-intensity 
exhaustive exercise, and after 1h of recovery.  Blood was collected into EDTA coated 
tubes and placed on ice.  Plasma and red blood cell (RBC) pellets were obtained by 
centrifugation of whole blood at 3000g for 10 minutes at 4ºC.  All blood analyses were 
corrected for changes in blood volume post exercise by measuring hemoglobin and 
hematocrit concentrations.  Plasma-free F2-isoprostanes was added to 300 µL of plasma, 
followed by ethanol and was chilled to precipitate proteins.  The samples were 
centrifuged through a series of washing steps.  A total of 50 µL of purified samples was 
analyzed with an F2-isoprostane immunoassay kit (Cayman Chemical).  Absorbance 
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values were determined using a plate reader at 405 nm.  The antioxidant capacity of 
plasma was analyzed using the ImAnOx Colorimetric test system.  A standard amount of 
hydrogen peroxide (H202) was added to plasma and the reaction was determined 
colorimetrically.  Plasma uric acid was analyzed using a commercial assay on a COBAS-
BIO centrifugal analyzer.  Absorbance was measured at 520 nm.  TGSH and GSSG were 
analyzed using a commercial assay (OxisResearch) using the Ellman’s reagent, which 
reacts with GSH to form a spectrophotometrically detectable complex at 412 nm.  
Vitamin E and β-carotene were separated by reverse phase high-performance liquid 
chromatography and measured using a programmable wavelength UV-visible detector.  
At 0.01 min, vitamin A was measured at 310 nm; at 5.5 min vitamin E was measured at 
280 nm and at 9.0 min, β-carotene was measured at 450 nm.  The R-AO diet induced a 
threefold reduction in antioxidant intake when compared with habitual antioxidant intake 
when compared with habitual-antioxidant (H-AO) diets.  F2-isoprostane concentration 
was significantly higher after submaximal (38%), exhaustion (45%), and 1 h of recovery 
(31%) when following the R-AO diet compared with the H-AO diet.  Rate of perceived 
exertion was increased on the R-AO diet although exercise time to exhaustion was not 
affected.  Total antioxidant capacity and circulating antioxidant concentrations tended to 
be lower when following the R-AO diet.  In summary, the athletes following a 2-week 
restricted antioxidant diet had an increased susceptibility to lipid peroxidation, even 
though their blood antioxidant defenses were not significantly decreased.  These findings 
highlight the vital and adequate role of high-antioxidant foods have in defending against 
oxidative stress.  However, according to the authors, there seems to be no valid reason to 
recommend antioxidant supplements to athletes participating in acute high-intensity 
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exercise events up to 40 min in duration except in those consuming a low-antioxidant 
diet. 
Beta-alanine and its role in increasing muscle carnosine levels. 
Baguet, Reyngoudt, Pottier, Everaert, Callens, Achten, Derave, 2009  [6] 
Carnosine Loading and washout in human skeletal muscles 
 
The aim of the present study was to investigate the magnitude of supplementation-
induced amplitude of carnosine synthesis and the time course of subsequent elimination 
on cessation of supplementation in different human skeletal muscle types, including the 
soleus, anterior tibialis, and medial gastrocnemius.  In a double-blind, randomized 
fashion fifteen male subjects supplemented with either placebo (maltodextrin) or beta-
alanine (Carnosyn, National Alternatives International) for 5-6 weeks.  Supplements were 
provided in capsules of 400 mg and were administered each day as six divided doses, 
with at least 2 h in between ingestions.  Daily doses consisted of 2.4 g/day during the first 
two days, 3.6 g/day during the subsequent two days, and from then on 4.8 g/day until the 
end of the supplementation.  Carnosine quantification was performed in the week before 
the start of supplementation (Pre), during the last week of supplementation (Post), and 3 
weeks and 9 weeks following the end of supplementation.  Carnosine content was 
measured using proton magnetic resonance spectroscopy in three skeletal muscles of the 
lower leg (%type I/II fibers: soleus, 86/14; tibialis anterior, 73/27; and gastrocnemius, 
44/56).  The beta-alanine supplementation significantly increase carnosine content in the 
soleus by 39%, +27% in the tibialis anterior and +23% in the gastrocnemius.  Following 
the three week washout 26.1% (p=0.171) of the increase in the soleus, 20.1% (p=0.50) of 
the increase in the tibialis and 44.7% (p=0.166) of the increase in the gastrocnemius had 
disappeared.  Nine weeks after cessation of supplementation, the carnosine content in the 
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soleus was not different from the initial carnosine content.  The carnosine concentration 
of the tibialis anterior and the gastroc also returned to their initial levels, representing a 
washout rate of 2.5%-3.5%/week.  When stratified for high responders and low 
responders, washout periods may range from 15 to 6 weeks, respectively.  
Dunnett, Harris, Dunnett, Harris, 2002  [33] 
Plasma carnosine concentration: diurnal variation and effects of age, exercise and 
muscle damage 
 
The aims of this study were to 1) measure the plasma carnosine concentration range in 
Thoroughbred horses of differing ages and genders; 2) study the 24 h variability in 
plasma carnosine in fed and fasted horses, and 3) investigate possible concentration 
changes associated with strenuous exercise and muscle damage.  Plasma carnosine 
concentrations were determined by high-performance liquid chromatography, and plasma 
aspartate transaminase and creatine kinase activities were determined by kinetic methods 
using a Kone Specific Autoanalyser.  Four separate studies were conducted within this 
investigation.  In study A, blood samples from Thoroughbred horses in training (26 
males, 30 females, 25 geldings), yearlings (13 males, 13 females) and foals (2 males, 3 
females) were drawn to determine plasma carnosine concentration and the influence of 
age and gender.  Study B evaluated the variations in plasma carnosine concentrations 
over 24 hours in a fed and fasted stated, separated by two days.  Plasma carnosine 
concentrations as a result of four-weeks of high-intensity exercise were measured before, 
5 min, 30 min, 2 hr and 24 h following a stepwise maximal treadmill test.  The final 
investigation measured the changes in plasma carnosine concentration following the 
onset of equine exertional rhabdomyolysis syndrome from three horses.  These 
investigations determined that carnosine is present in equine plasma, in contrast to man, 
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with levels consistent with the absence of carnosinase.  More so, there was a significant 
effect of age on plasma carnosine concentrations in resting Thoroughbred horses. Values 
in horses age three and older were 11.3-14.1 µmol/l, compared to young (foals/yearlings) 
were 3.9-8.7 µmol/l and therefore may reflect lower skeletal muscle carnosine 
concentrations.  When looking at within-day variation of plasma carnosine 
concentrations, there were no differences between fed and fasted levels.  Intense exercise 
resulted in a small significant increase in plasma carnosine concentration (pre-exercise: 
10.3 ± 1.0 µmol/l; post-exercise: 12.4 ± 4.4 µmol/l).  In conclusion, elevated plasma 
carnosine concentrations are observed following exercise induced muscle damage.  
Plasma carnosine measurements could provide an alternative clinical indicator of muscle 
damage; and in conjunction with plasma taurine measurements may be indicative of 
selective type 1 or type 2 muscle fiber damage. 
 
Dunnett, Harris, 1999  [32] 
Influence of oral β-alanine and L-histidine supplementation on the carnosine 
content of the gluteus medius 
 
The aim of the present study was to evaluate the hypothesis that in vivo carnosine 
biosynthesis may be dependent upon the availability of endogenous beta-alanine, by 
studying the effect of chronic dietary beta-alanine supplementation in the horse on the 
carnosine concentrations in type I, IIA and IIB skeletal muscle fibers.  The diets of six 
un-trained Thoroughbred horses were supplemented three times daily, for 30 days, with 
beta-alanine (300 mg/kg body weight) along with a comparatively low dose of L-
histidine (37.5 mg/kg body weight) to ensure an adequate supply for carnosine synthesis.  
On day one and day 30 of the supplementation, venous blood samples were collected via 
an indwelling catheter.  Blood samples were also taken on days 6, 18, and 24.  Muscle 
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samples were collected by percutaneous biopsy from the right m. gluteus medius on the 
day immediately before supplementation commenced (Day 0) and on the day 
immediately after (Day 31).  Plasma beta-alanine, L-histidine and carnosine 
concentrations were determined by HPLC.  Individual muscle fibers were dissected from 
freeze-dried biopsies and analyzed for carnosine and taurine.  Fragments of individual 
muscle fibers were characterized at types I, IIA or IIB by histochemical staining for 
myosin ATPase. Results indicate that there was an adaptive response to sustained beta-
alanine administration resulting in mean ± SD beta-alanine AUC values increasing 
significantly from 1130 ± 612 µmol/l (Day 1) to 2490 ± 1416 µmol/l (Day 30), 
suggesting increased beta-amino transport across the gastrointestinal lumen.  There was 
no consistent increase in histidine AUC between Days 1 and 30 [757 ± 447 µmol/l (Day 
1) and 1162 ± 1084 µmol/l (Day 30)].  Type IIA fiber carnonsine concentrations 
increased from 59.9-102.6 to 76.2-112.2 mmol/kg dry weight, with significance resulting 
in only two of the six horses.  Type IIB fiber carnosine concentrations increased from 
101.3-131.2 to 114.3-153.3 mmol/kg, with significance increases in five of six horses.    
In conclusion, results from this investigation clearly support the hypothesis that in vivo 
the magnitude and rate of carnosine biosynthesis is greatly influenced by the availability 
of beta-alanine.  Chronic dietary supplementation with beta-alanine can increase muscle 
carnosine concentration in the horse. 
 
Harris, Tallon, Dunnett, Boobis, Coakley, Kim, Fallowfield, Hill, Sale, and Wise 2006  
[46] 
The absorption of orally supplied β-alanine and its effect on muscle carnosine 
synthesis in human vastus lateralis 
The aim of this study was to investigate the intramuscular availability of β-alanine 
supplied orally and the effect of supplementation on muscle carnosine synthesis.  A series 
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of 3 studies were utilized to investigate the bioavailability of β-alanine.  Study 1 used a 
crossover design in which six male subjects (Age: 33.5 ± 9.9 yrs; Wt: 80.2 ± 17.1 kg) 
underwent four treatments, out of a possible five.  All subjects ingested 8 ml·kg
-1
 bwt of 
chicken broth containing a total of 40 mg·kg
-1
 bwt β-alanine in the form of anserine and 
carnosine (Treatment A).  For treatments B, C, D and E, 3 of the possible 4 treatments 
were randomly ordered within and between the six subjects.  Each subject ingested 3 
ml·kg
-1
 bwt of a drink containing B) 0 (control), C) 10, D) 20, or E) 40 mg·kg
-1
 bwt β-
alanine, followed by ingestion of 5 ml·kg
-1
 bwt of water.  Venous blood and urine 
samples were collected at 10 min intervals for the first 90 min up to 360 min and for 9 
hours, respectively.  Study 2: Six male subjects (Age 28.3 ± 2.7 yrs; Wt 83.2 ± 14.3 kg) 
were catheterized after a 12 hr fast.  Each subject was given three doses of 10 mg·kg
-1
 
bwt β-alanine at 0 (9 am), 3 and 6 hours.  Blood samples were taken up to 9 hours after 
supplementation.  Subjects continued to take the supplement 3 times per day for 15 days, 
on the 15
th
 day, a second blood draw was performed.  Study 3: The purpose of this 
segment of the study was to evaluate the effect of 4 weeks of dietary β-alanine 
supplementation or carnosine on muscle carnosine content.  The main study was 
preceded by a 15-day investigation where sixteen male subjects (Age 19.4 ± 1.6 yrs; Wt 
79.5 ± 9.3 kg) were randomly assigned to either β-alanine (n = 8; 800 mg) or matching 
placebo (n = 8) and instructed to take two, 400 mg capsules at 9 am, 12 pm, 3 pm, and 6 
pm.  Following the 15 day pre-study investigation, 21 male subjects (Age 26.1 ± 5.6 yrs, 
Wt 79.5 ± 10.5 kg) ingested β-alanine using one of two protocols; (I and II, n = 5 each); 
I: 800 mg of β-alanine was given 4 times per day (~3.2 g); II: 800 mg using a more 
frequent dosing strategy, on average consuming ~ 4 grams per day; or treatments III and 
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IV. III: Subjects ingested L-carnosine in the same dosing pattern as treatments II and IV: 
control subjects consumed a maltodextrin capsule to match groups II and III.  Study 1: β-
alanine increased in plasma following ingestion of all treatments, excluding 0 mg·kg
-1
, 
and was ~ ½ of the ingested solution.  Carnosine was not detected in the plasma.  Time to 
peak plasma concentration of all concentrations was between 30-40 minutes.  In addition, 
a 6-8 fold increase was seen with 10 to 20 mg·kg
-1
 ingestion.  Taurine concentration was 
also increased.  Study 2 showed similar increases in plasma β-alanine concentrations and 
time to peak as in study 1.  In addition, the time between dosing allowed plasma levels to 
return to baseline and avoided the flushing sensation.  Study 3 showed no significant 
changes by the end of 4 weeks supplementation with 4 x 800 mg β-alanine, whereas there 
was a significant increase in carnosine levels with L-carnosine supplementation.   
Suzuki, Nakao, Maemura, Sato, Kamahara, Morimatsu, and Takamatsu, 2006  [104] 
Carnosine and anserine ingestion enhances contribution of nonbicarbonate 
buffering 
The purpose of this study was to examine the influence of oral supplementation with 
chicken breast extract (CBEX), which is a rich source of carnosine and anserine, on acid-
base balance and performance during intense intermittent exercise.  Eight moderately 
trained men (age: 19.8 ± 0.5 yrs, Ht: 171.8 ± 2.3 cm, Wt: 64.7 ± 2.7 kg) performed 
intense intermittent exercise that consisted of ten, 5-s maximal sprints on a cycle 
ergometer, with 25-s recovery.  Each subject ingested 190 g of either CBEX or placebo in 
a soup consistency, 30 minutes before beginning the exercise.  Arterial blood samples 
were collected at rest, 1 minute before the start of the test, after each set, and immediately 
after the last set.  Hydrogen-ion concentration (pH), carbon dioxide partial pressure 
(pCO2), bicarbonate ion concentration (HCO3
-
), blood lactate (La), and the 
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concentrations of carnosine, anserine, and the other constitutive amino acids were 
measured.  Concentrations of anserine significantly increased 30 minutes after CBEX 
supplementation.  Carnosine however, did not improve significantly.  Two other 
constituents, β-alanine (27.2 ± 5.9 to 33.6 ± 6.8 μmol·L-1) and histidine (93.3 ± 12.5 to 
100.9 ± 11.3 μmol·L-1) were significantly increased from pre- to post-, respectively.  In 
addition, following CBEX supplementation and the cessation of exercise, the pH and 
HCO3
-
 values were elevated significantly.  After both the CBEX and placebo treatments, 
the La concentration increased throughout and after the exercise, and pCO2 increased 
throughout the exercise, but decreased following cessation of exercise. With regard to the 
mean power output for each interval set, there were no significant differences observed 
between the CBEX and placebo group.  Furthermore, there were no significant 
differences between either group, for mean power for all 10 sets (9.35 ± 0.18 W·kg
-1
 
(CBEX), 9.50 ± 0.19 W·kg
-1
(Pl)).   
The effects of beta-alanine supplementation on performance. 
Suzuki, Ito, Mukai, Takahashi, and Takamatsu, 2002  [103] 
High level of skeletal muscle carnosine contributes to the latter half of exercise 
performance during during 30s maximal cycle ergometer sprinting 
 
The purpose of this study was to examine the relationship between the carnosine 
concentration in skeletal muscle, fiber-type distribution, and high-intensity exercise 
performance.  Eleven recreationally active men (age: 21.7 ± 1.4 years, Ht: 171.8 ± 6.1 




) performed an initial 30-s 
maximal cycle ergometer sprint at 7.5% of their body weight.  To determine the 
intramuscular concentration of carnosine, muscle biopsies were taken from the vastus 
lateralis, 6-7 days before the sprint cycle bout, and further analyzed with an amino acid 
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auto analyzer.  Fiber-type distribution was also analyzed.  The carnosine concentration 
was significantly correlated with mean power (r = 0.785), and demonstrated a positive, 
but non-significant correlation with peak power (r = 0.598).  The correlations observed 
between the carnosine concentration and the mean power of the final 2 phases of the 30-s 
sprint, were the most highly correlated (21-25s: r = 0.694; 26-30s: r = 0.660).  A 
significant, positive correlation between % Type IIx fiber type content and carnosine 
concentration was reported.  In addition, % Type IIx fiber area was significantly 
correlated with mean power (r = 0.809) and peak power (r = 0.732). 
 
Stout, Cramer, Zoeller, Torok, Costa, Hoffman, and Harris, 2007  [101] 
Effects of beta-alanine supplementation on the onset of neuromuscular fatigue and 
ventilator threshold in women 
The purpose of this study was to examine the effects of 28 days of β-alanine 
supplementation on PWCFT, VT, VO2max and TTE in women.  This double-blind, 
randomized, placebo controlled study, included 22 women (age: 27.4 ± 6.1 yrs) that were 
placed into a β-alanine (n = 11) or placebo (n = 11) group.  Each subject went through a 
series of tests to measure PWCFT, VO2max, VT, and TTE, before and after the 
supplementation period.  All data was collected and values were determined from one 
initial trial of the PWCFT.  Subjects performed a graded cycle ergometer test, beginning at 
40 W and increasing 20 W every 3minutes until the individual could no longer maintain a 
speed of 70 rpm.  During the PWCFT test, oxygen consumption measurements were 
collected, using open circuit spirometry and used to calculate VO2MAX and VT.  In 
addition, bipolar surface electrodes were placed over the vastus lateralis of the right thigh 
to collect muscle activity. Following initial testing, subjects began a 28 day 
supplementation period in which β-alanine was taken at 4 different times each day.  
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During days 1-7, 3.2 g·d
-1
 were consumed, and 6.4 g·d
-1
 were taken for the remaining 
duration (days 8-28).  There were 13.9, 12.6 and 2.5% significant increases in VT, 
PWCFT, and TTE, respectively, for the β-alanine group, but no changes observed in the 
placebo group.  However, there were no changes in VO2max, for either group.  In 
addition, there was no significant difference between groups for their compliance rate 




Hill, Harris, Kim, Harris, Sale, Boobis, Kim, and Wise, 2006  [47]  
Influence of beta-alanine supplementation on skeletal muscle carnosine 
concentrations and high intensity cycling capacity 
The aims of this study were to examine the effects of a 10 week β-alanine 
supplementation protocol on muscle carnosine accumulation to determine if changes 
were specific to Type I or Type II muscle fibers, and to determine the effects of β-alanine 
on performance during a high-intensity, endurance cycling capacity test.  Twenty-five 
physically active males were randomly assigned to either a β-alanine (β-ala, n = 13) or a 
placebo group (P, n = 12) (age: β-ala: 25.4±2.1, P: 29.2 ± 6.9 yrs, Ht: β-ala: 184.1±7.5, P: 
182.1±7.9 cm).  Subjects performed a high-intensity cycling test in which the power 
output began at 100 or 150 W, depending on fitness, with an increasing intensity of 12.5 
W every 30 s until volitional exhaustion.  Maximum power output was calculated and 
used at a 110%, to complete two cycle capacity tests (CCT110%).  Subjects exercised at 
power outputs corresponding to 80% of VO2max (Wmax) for the first 15 s, 95% Wmax 
for the second 15 s and then 110% Wmax until volitional exhaustion.  The time and 
average power output were recorded and used to calculate total work done (TWD: 
average power (W) x time (seconds).  To evaluate the changes in intramuscular carnosine 
34 
 
concentration, muscle biopsies were taken and analyzed by HPLC from the mid section 
of the vastus lateralis, 1-2 days after the pre-supplementation cycle test, and 1-2 days 
after the 4 and 10 week tests.  Muscle carnosine concentrations were significantly 
increased by 58.8% and 80.1% after 4 and 10 weeks of β-alanine supplementation, 
respectively.  The initial carnosine concentration was 1.71 times higher in type IIa fibers 
than in Type I fibers, but increased equally in both Type I and IIa fibers, but, there were 
no increases observed in the placebo group.  TWD was significantly increased following 
4 and 10 weeks of β-alanine supplementation (7.3 ± 1.3 and 8.6 ± 3.1 kJ), compared with 
no change in the placebo group.  In addition, TWD and increased muscle carnosine 
concentration were correlated, but not significant. 
Van Thienen, Van Proeyen, Eynde, Puype, Lefere, Hespel, 2009 [106] 
β-Alanine improves sprint performance in endurance cycling 
 
Van Thienen and colleagues investigated the effect of short-term β-alanine (βALA) 
administration in a simulated cycling race.  In a double-blind, placebo-controlled 
approach, 17 male cyclists supplemented for eight weeks with βALA or placebo (PL), 
interspersed with two experimental sessions (pretesting vs. posttesting).  βALA was 
administered in 500-mg capsules to be ingested at regular intervals throughout the day.  
Dosage was gradually increased from 2 g·d
-1
 (weeks 1 and 2) to 3 g·d
-1
 (weeks 3 and 4) 
and eventually 4 g daily from week 5 to the end of the study.  PL capsules contained 
maltodextrin.  Subjects completed an initial incremental exercise test starting at 100 W 
and increasing 40 W per 8-minute stages until volitional exhaustion.  One week later (and 
following 8 weeks of supplementation), the subjects participated in a simulated road race, 
receiving a standardized dinner the evening before.  The exercise protocol started with a 
110-min intermittent endurance exercise bout during which exercise intensity was varied 
35 
 
between 50% and 90% (10-min stages) of their previously estimated max.  Immediately 
at the end of the intermittent exercise bout, a 10-min time trial was started at 100% max 
workload (~89% VO2max), with the subjects voluntarily increasing/decreasing the 
workload at 1-min intervals according to their perception of fatigue.  At the end of the 
time trial, subjects were allowed to recover for 5 min at a workload corresponding to 50% 
of their max.  Finally, they performed a 30-s all-out sprint in an isokinetic mode.  Mean 
power output during the time trial was approximately 300 W and was similar between PL 
and βALA during both the pretesting and the posttesting.  However, compared with PL, 
during the final sprint after the time trial, βALA increased by 11.4% (95% confidence 
interval = +7.8 to + 14.9%), on average, whereas mean power output increased by 5.0% 
(95% confidence interval = +2.0 to +8.1%).  Blood lactate and pH values were similar 
between group at all times points.  In conclusion, oral βALA supplementation can 
significantly enhance sprint performance at the end of an exhaustive endurance exercise 
bout. 
 
Carnosine as an antioxidant 
Babizhayev, Seguin, Gueyne, Evstigneeva, Ageyeva, Zheltukhina, 1994 [5] 
L-carnosine (β-alanyl-L-histidine) and carcinine (β-alanylhistamine) act as natural 
antioxidants with hydroxyl-radical scavenging and lipid-peroxidase activities 
 
The purpose of this study was to elucidate the molecular basis of the protective effect of 
carnosine in biological systems by testing the anti- or pro-oxidant activities of carnosine 
and other imidazole-containing compounds (i.e. carcinine, histamine, and histidine) 
physiologically linked to carnosine in the carnosine-histidine-histamine metabolic 
pathway.  Both carnosine and carcinine (10-25 mM) are capable of inhibiting the 





 dependent ion-ascorbate and lipid-peroxyl-radical generating linoleic acid 13-
monohydroperoxide (LOOH)-activated haemoglobin systems, as measured by 
thiobarbituric-acid-reactive substance. Linoleic hydroperoxide was quantified using an 
iodometric technique.  Peroxidation of the phosphatidylcholine liposomes or the 
emulsion of linoleic acid was initiated, and the concentration of LPO products in the 
oxidized lipid substrates were measured by reaction with thiobarbituric acid.  Carcinine 
and carnosine are good scavengers of OH
.
 radicals, as detected by iron-dependent radical 
damage to the sugar deoxyribose suggesting that carnosine and carcinine are able to 
scavenge free radicals or donate hydrogen ions.  The iodometric, conjugated diene and 
t.l.c. assessments of lipid hydroperoxides (13-monohydroperoxide linoleic acid and 
phosphatidylcholine hydroperoxide) showed their efficient reduction and deactivation by 
carnosine and carcinine in the liberated and bound-to-artificial-bilayer states.  Different 
constituents and imidazole-containing compounds were compared for their ability to 
inhibit the iron-ascorbate and LOOH/Hb-dependent oxidation of LA and PC liposomes.  
The results demonstrate that carnosine and carcinine significantly inhibited the LPO 
reaction at 5-25 mM concentration.  The constituents histidine and histamine exhibited 
stimulatory peroxidative effects for free LA or PC liposomes.  The other tested 
compounds, i.e. imidazole, beta-alanine and the mixtures of beta-alanine + histidine or 
beta-alanine+ histamine, were inactive or showed a slight stimulatory activity to LPO 
suggesting that the redox potential of the whole β-alanyl-imidazole-containing molecule 
is essential for its antioxidant activity.  Both carnosine and carcinine were effective at 
inhibiting the production of TBARS in the LOOH-activated Hb catalysis of LPO (which 
is not sensitive to chelating agents) suggesting that the antioxidant mechanism depended 
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on the ability to scavenge lipid peroxy radicals or donate hydrogen ions and not solely on 
chelation.  Degradation of deoxyribose was found to be strongly inhibited by carnosine 
and carcinine and therefore delaying a rise in OH
.
 radicals.  These results suggest that 
carnosine and carcinine appear to be physiological antioxidants able to efficiently protect 
the lipid phase of biological membranes and aqueous environments. 
protect the lipid phase of biological membranes and aqueous environments. 
Boldyrev, Stvolinsky, Tyulina, Koshelev, Hori, Carpenter, 1997 [20] 
Biochemical and physiological evidence that carnosine is an endogenous 
neuroprotector against free radicals 
 
The current study examined the actions of carnosine and its natural derivatives on two 
isolated enzyme systems, and on two physiological models of hypoxia, to test their 
protecting efficiency on the brain systems under injury. Na/K-ATPase was prepared from 
ox brain gray matter and assayed for activity by determining inorganic phosphate 
released.  Oxidation was triggered by adding 10 mM hydrogen peroxide prior to activity 
determination for periods of up to 40 min, and controls, buffered with PIPES, compared 
with preparations of enzyme containing either carnosine of homocarnosine.  Ischemia 
was applied to living brain slices, immersed in oxygenated Krebs-Ringers solution and 
then stimulated on the lateral olfactory tract.  Additionally, whole-animal hypoxia 
experiments were performed on ten white rats in each experimental group.  Each animal 
was injected with either carnosine (250 mg/kg) or saline in a single intraperitoneal 
injection 20 mi prior to the experiment.  Experiments were performed in a 5-L chamber 
with equalized pressure corresponding to an altitude of 10,500 m above sea level.  The 
resistance of each rat to hypoxia was judged by the time interval to loss of ability to 
stand, as well as the time to cessation of spontaneous breathing.  After cessation of 
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breathing, the pressure was returned to atmospheric levels and the time needed to recover 
the ability to stand was recorded.  Boldyrev and colleagues demonstrated that both 
carnosine and homocarnosine had a facilitating effect on inorganic phosphate liberations 
by ATPase, even at time 0.  The enzyme activity in the control decayed rapidly over the 
40 min experiement, as the result of destruction triggered by the hydrogen peroxide, 
while both carnosine and homocarnosine were shown to be protective.  The ability of 
carnosine to function as a OH
.
 scavenger should serve to protect NA/K-ATPase and 
support functional activity of neurons. Additionally, tyrosine hydoxylase is a system for 
assay of oxidant actions.  In the presence of carnosine (20 µM) and homocarnosine, 
tyrosine hydoxylase was found to be reduced to 26% and 60% of the control, 
respectively.  With respect to evaluating whether carnosine can protect the brain from 
ischemic damage, Boldyrev et al fail to demonstrate direct excitation of neurons by 
carnosine suggesting that carnosine does not operate as a neurotransmitter, which is 
consistent with previous literature.  More so, when relating carnosine to whole-animal 
hypoxia, carnosine resulted in a strong protective action delaying the time to loss of 
coordination and cessation of breathing and shortening the recovery. In summary, 
although there is no evidence that carnosine alters neuronal excitability of modulation of 
synaptic transmission, as least one function of carnosine may be to prevent damage to the 
cell from production of reactive oxygen species. 
Boldyrev, Song, Lawrence, Carpenter, 1999 [16] 
Carnosine protects against excitotoxic cell death independently of effects on reactive 
oxygen species 
 
This investigation explored the actions of carnosine, homocarnosine and N-
acetylcarnosin on acutely isolated cerebellar granule cells, studied in a flow cytometer 
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monitoring cell death upon application of excitatory amino acids and measuring ROS 
accumulation.   Wistar rats (10-12 days-old weight 18-22 g) were used in all experiments.  
Cerebellar granule cell neurons were obtained from cerebellum slices that were incubated 
and filtered.  Changes in ROS concentration were measured by use of 2’,7’-
dichlorofluorescein diacetate (DCF-DA) to determine oxidation and damage plasma 
membranes.  In order to distinguish necrotic from apoptic cell death FITC-labeled 
Annexin-V was used to detect cells in early apoptosis.  Using the method of blotting 
propidium iodide (PI) allowed the authors to follow the progression to cell death by either 
necrosis or apoptosis.  For all of the flow cytometric measurements, carnosine, 
homocarnosine or N-acetylcarnosine were added to the cells at the beginning of the 1 h 
incubation period at a concentration of 10 mM.  Boldyrev and colleagues reported that 
carnosine, N-acetylcarnosine and homocarnosine at physiological concentrations are all 
potent in suppressing fluorescence of 2’,7’-dichlorofluorescein, which reacts with 
intracellularly generated reactive oxygen species.  Only carnosine in the same 
concentration range was effective in preventing apoptotic neuronal cell death as 
demonstrated from the DNA binding dye, PI and FITC-labeled Annexin-V.  These results 
indicate that carnosine and related compounds are effective scavengers of reactive 
oxygen species generated by activation of ionotropic glutamate receptors, but this action 
does not prevent excitotoxic cell death.  Some other process, which is sensitive to 
carnosine, but not the related compounds is a critical factor in cell death.   
Chan, Decker, Chow, Boissonneault, 1994 [22] 
Effect of dietary carnosine on plasma and tissue antioxidant concentrations and on 




The objective of the present study was to determine how dietary carnosine, at a 
concentration equivalent to that in a diet containing 20% beef, would affect carnosine, 
anserine, histidine and α-tocopherol concentrations in both α-tocopherol-deficient and α-
tocopherol-adequate rats.  The secondary aim of this study was to determine the effect of 
dietary carnosine and α-tocopherol on the formation of thiobarbituric acid reactive 
substances (TBARS) in rat skeletal muscle homogenates. Utilizing three groups 
containing 1) 0.0875% carnosine, 2) α-tocopherol acetate or 3) or carnosine (0.0875%) 
plus α-tocopherol acetate.  Carnosine, anserine and histidine concentrations in the 
derivatized extract were determined by HPLC using an FS 970 Spectrofluoro Monitor at 
310 nm for excitation and 375 nm for emission, based on peak areas and standard curves 
obtained on 10-100 µg/mL of carnosine and histidine and 100-500 µg/mL anserine. 
Dietary supplementation with carnosine did not increase carnosine concentrations in 
heart, liver or skeletal muscle.  Dietary supplementation with both carnosine and α-
tocopherol increased carnosine concentrations in liver 1.56-, 1.51- and 1.51-fold as 
compared with diets lacking carnosine, α-tocopherol or both carnosine and α-tocopherol, 
respectively.  To determine the oxidation of skeletal muscle homogenates the extent of 
lipid oxidation was determined at various time points by measuring TBARS. Dietary 
supplementation with carnosine, α-tocopherol or both carnosine and α-tocopherol was 
effective in decreasing the formation of TBARS with α-tocopherol and α-tocopherol plus 
carnosine being more effective than carnosine alone.  In summary, dietary carnosine 
supplementation did not affect carnosine concentrations in heart, liver and skeletal 
muscle.  Dietary supplementation with carnosine, α-tocopherol, or both carnosine and α-
tocopherol effectively decreased lipid oxidation in rat skeletal muscle.     
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Decker, Crum, Calvert, 1992 [27] 
Differences in the antioxidant mechanism of carnosine in the presence of copper and 
iron 
 
The objectives of this research were to determine if the antioxidant mechanism of 
carnosine was different in the presence of copper or iron.  Differences in antioxidant 
mechanism were determined by the ability of carnosine to chelate iron and copper as 
determined by changes in the catalytic activity of the metals and by changes in the 
1
H 
NMR spectra of carnosine in the presence of iron or copper.  Carnosine (1.0-25 mM) is 
capable of inhibiting copper- and iron-catalyzed oxidation of phosphatidylcholine 
liposomes.  Lipid oxidation was performed in a model system containing 0.02 mg of 
phophatidylcholine liposomes/mL of 0.12 M KCl-5 mM histidine buffer (pH 7.0) plus 
ascorbate, FeCl3 or CuCl2 and various concentrations of carnosine.  All reactions were 
run at 37˚C for 30 min.  Lipid oxidation was monitored by measuring thiobarbituric acid 
reactive substances (TBARS) and lipid peroxides with assays containing 0.3 mM ADP, 
0.3 mM NADPH, 10 µM FeCl2, 25 mM carnosine, and 0l5 mg of microsomal protein per 
ml of 0.12 M KCl-5 mM histidine buffer, compared to controls void of carnosine.  
Percent inhibition was calculated as (1-[(activity in the presence of inhibitor)/(activity in 
the absence of inhibitor)])x 100. 
1
H NMR spectra of carnosine and carnosine in 
combination with either copper or iron were recorded on a Varian VXRS-400 
spectrometer at 400 MHz.  Decker et al. demonstrated that carnosine was capable of 
inhibiting both iron- and copper-catalyzed oxidation of phosphatidylcholine liposomes.  
When lipid oxidation was measured by TBARS, low carnosine concentrations (≤10 mM) 
more effectively inhibited lipid oxidation catalyzed by copper than by iron.  At 1, 5, and 
10 mM, carnosine inhibition of TBARS production was 11-, 2.6-, and 1.3-fold higher in 
42 
 
the presence of copper than in iron. At higher carnosine levels, antioxidant responses 
were similar between iron and copper.  More so, the antioxidant activity of carnosine was 
greater in the presence of copper than of iron when measuring the oxidation of 
phosphatidylcholine liposomes by lipid peroxides.  Neither hisitidine or beta-alanine (25 
mM) was found to inhibit iron- or copper-catalyzed formation of TBARS or lipid 
peroxides.  Low concentrations of carnosine (0.1 and 0.05 mM) slightly accelerated the 
catalysis of ascorbate oxidation by both metals, whereas higher concentrations had no 
effect.  Carnosine was also capable of inhibiting ghost production of TBARS by and 
iron/NADPH-dependent lipid oxidation system in chicken muscle microsomes.  In 
summary, in addition to iron and copper, carnosine can also inhibit nonmetal lipid 
oxidation catalysts including peroxyl radicals, lipoxidase, and photoactivated riboflavin.  
The ability of carnosine to inhibit iron-catalyzed lipid oxidation without chelation and the 
ability of carnosine to inhibit nonmetal lipid oxidation catalysts suggest that carnosine 
could be capable of inactivating free radicals and therefore its antioxidant mechanism 
may be multifunctional. 
 
Decker, Ivanov, Zhu, Frei, 2001 [28] 
Inhibiton of low-density lipoprotein oxidation by carnosine and histidine 
 
This research investigated the ability of carnosine to inhibit the oxidation of low-density 
lipoprotein (LDL) in comparison to its constituent amino acid, histidine.  Carnosine was 
obtained from Sigma Chemical Co. and LDL was prepared from blood plasma of healthy 
individuals.  Oxidation of LDL (20 µg of protein/mL of PBS) was promoted by either 
Cu
2+
 or 2-amidinopropane dihydrochloride (AAPH).  Measurment of TBARS was 
performed to assess oxidation. Comparisons of the inhibitory effects of carnosine and 
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hsitidine were determined within the same experiment to minimize variations.  The 
ability of carnosine and histidine to alter the redox cycling of copper was determined by 
monitoring changes in Cu2+-promoted ascorbic acid oxidation rates.  None of the 
carnosine concentrations tested (3.0-24.0 µM) inhibited Cu
2+-
promoted tryptophan 
oxidation after two hours of incubation.  Carnosine (3 µM) inhibited Cu
2+-
promoted LDL 
oxidation at carnosine/copper ratios as low as 1:1 as determined by loss of tryptophan 
fluorescence and formation of conjugated dienes after three hours.  Carnosine (6 µM) lost 
its ability to inhibit conjugated diene formation and tryptophan oxidation after two and 
four hours of incubation.  Carnosine and histidine were able to significantly inhibit 
carbonyl formation in both oxidation systems at concentration ≥0.2 mM.  The ability of 
carnosine and histidine to inhibit LDL oxidation by inactivating free radicals was 
determined by oxidizing LDL with peroxyl radicals generated from AAPH.  At higher 
concentrations (250 µM) both purified carnosine and histidine have been found to inhibit 
the peroxyl radical with no differences between dipeptides.  The current study 
demonstrated that histidine was more effective at inhibiting copper-promoted formation 
of carbonyls on bovine serum albumin than carnosine, but carnosine was more effective 
at inhibiting copper-induced ascorbic acid oxidation than histidine.  Neither dipepetide 
was a strong inhibitor of AAPH-promoted oxidation of LDL, indicating that their main 
antioxidant mechanism is through copper chelation. 
 
Kohen, Yamamoto, Cundy, Ames, 1988 [63] 
Antioxidant activity of carnosine, homocarnosine, and anserine present in muscle 
and brain 
 
The aim of the current study was to explore the role of carnosine and its analogues 
(homocarnosine and anserine) as protectors against oxidative stress and the continued 
44 
 
possibility of carnosine and related compounds of serving as natural antioxidants in 
skeletal muscle and brain.  Using Sigma materials the azo compounds 2,2’-azobis(2,4-
dimethylvoleronitrile) (AMVN) and 2,2’-azobis(2-amidinopropane dihydrochloride) 
(AAPH) were used as free-radical initiators in both homogeneous and liposome system.  
The rate of peroxyl-radical formation from these initiators is constant at a given 
temperature and, once produced, can initiate free-radical chain oxidation. The free-radical 
chain oxidation products linoleic acid hydroperoxide and was determined by injection of 
10 µl of the reaction solution onto a 25-cm oxtadecylsilane LC-18 column.  The 
oxidation of soybean PtdCHo was measured by the formation of PtdCho hydroperoxide.  
The effects of carnosine were also measured by the formation of 8-hydroxy-
deoxyguanosine (8-OHdGuo).  The pH of all solutions were tested and adjusted to 7.2-
7.6.  Results from this study demonstrated that when carnosine was introduced into the 
AMVN and linoleic reaction mixture, there was a decrease in the rate of oxidation of 
linoleic acid to linoleic acid hydroperoxide.  Carnosine at concentrations of 1, 7.5, and 10 





.  The evaluation of antioxidant activity in the AAPH system were minimized, similar to 




for the same carnosine concentrations 




.  Homocarnosine and anserine 
demonstrated similar antioxidant protective activity at 56% protection compared to 53% 
protection of carnosine.  The structural component responsible for the antioxidant activity 
was evaluated demonstrating that L-Alanyl-L-histidine (which differs from carnosine 
only in the form of the amino acid alanine), shows a less-pronounced antioxidant activity 
than carnosine.  The alanyl residues alone (L-alanine or β-alanine), the combination of 
45 
 
both (l-alanyl-l-alanine or β-alanyl-l-alanine) and γ-aminobutryric acid (GABA) (present 
in homocarnosine) failed to show any antioxidant activity, suggesting that the imidazole 
ring is responsible for the antioxidant activity.  Carnosine prevented oxidative damage of 
deoxyguanosine induced by ascorbic acid and copper ions.  Conclusions regarding 
carnosine, homocarnosine and anserine suggest antioxidant activity.  All of these 
compounds showed peroxyl radical trapping activity and were electrochemically active as 
reducing agens.  Furthermore, carnosine inhibited the oxidative hydroxylation of 8-
OHdGuo induced by copper ions.  Kohen and colleagues also demonstrate other roles of 
carnosine, such as chelation of metal ions, quenching of singlet oxygen, and binding of 
hydroperoxides. 
 
Egorov, Kurella, Boldyrev, Krasnovsky, 1997 [35] 
Quenching of singlet molecular oxygen by carnosine and related antioxidants. 
Monitoring 1270-nm phosphorescence in aqueous media 
 
The goal of the current study was to quantitatively assess the rate constants of 
l
O2 
quenching by carnosine and its components: beta-alanine, L-histidine, and imidazole, and 
compare their activities with other natural metabolites of muscle tissues- anserine and 
taurine that are considered to contribute to tissue antioxidant systems.  
l
O2 quenching was 
obtained using the most reliable method, by time-resolved monitoring of 1270-nm 
l
O2 
phosphorescence.  In short, utilizing a series of pulse beams at differing wavelengths 
allowed for measurement of phosphorescence kinetics, quantifying the quenching 
activities (Kq) for taurine, L-anserine, L-carnosine, imidazole, L-histidine, ergothioneine, 
and beta-alanine.  The rate constants of 
l
O2 quenching (Kq) for carnosine, histidine, and 








.  The activity 
of non-aromatic amino acids – taurine and beta-alanine, demonstrated very low 
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.  These results indicate that the imidazole residue in 
the carnosine molecule is responsible for its quenching activity and the peptide body 
between histidine and alanine does not influence the Kq value.  Additionally, taurine did 
no show any measureable quenching activity in the concentration range.  The results of 
the current study suggest that the dipeptides can be used as potent water-soluble 
protectors against 
l
O2 attack whereas under natural conditions, either radical scavenging 
or other biochemical properties of carnosine, related histidine-containing dipeptides and 
taurine may be more important for other biological functions rather than interaction with 
singlet oxygen. 
 
Salim-Hanna, Lissi, Vid, 1990 [91] 
Free radical scavenging activity of carnosine 
 
The aim of the current study was to assess the ability of carnosine to interfere with the 
free radical-mediated inactivation of horseradish peroxidase and lysozyme, and to inhibit 
lipid peroxidation either in a metal-depended process (oxidation of brain homogenates) or 
in a metal-independent system (red cell membranes supplemented with 2,2’-azobis-(2-
aminopropane) (ABAP)).  Thiobarbituric acid reactive substance (TBARS) of lipid 
peroxidation were determined in brain homogenates and erythrocyte ghost membranes 
before and after 1 hours incubation.  Horseradish peroxidase activity was measured by 
recording the increase in absorbance at 420 nm produced as a consequence of the 
oxidation of pyrogallol.  Solutions of lysozyme and/or tryptophan, with or without 
carnosine were incubated to evaluate lysozyme activity from the lysis rate of micrococcus 
luteus.  Carnosine addition up to 17 mM did not produce any protection in either lipid 
peroxidation system, as assayed by the oxygen uptake rate.  However, results obtained for 
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carnosine and beta-alanine indicate that both additive concentrations are able to afford 
complete protection to the HRP enzyme and lysozymal radical mediated inactivation.  
The mean carnosine concentrations required to inhibit the inactivation by 50% were 0.13 
mM and 0.6 mM for HPR and lysozyme, respectively.  Furthermore, while carnosine is 
not particularly reactive towards alkylperoxyl radicals, its capacity to interact with these 
radical might contribute to decreasing protein damage by reactive oxygen species.  When 
evaluating lipid peroxidation, results demonstrated that carnosine did not alter the 
erythrocyte ghost membrane system.  In conclusion, carnosine does not prevent metal 
ion-independent oxidation of red cell membranes, and has only a small effect upon the 
brain homogenate oxidation rate, when employed in high concentration.  More so, the 
addition of L-histidine or beta-alanine up to 12 mM did not produce any noticeable 

















 Fifty-four moderately trained men (N=26) and women (N=28) were recruited for 
this investigation.  One male subject was lost during pre-testing due to a musculoskeletal 
injury.  One male was excluded from the oxidative stress analyses due to scheduling.  
Two females dropped out due to the inability to complete the 40 minute run and a 
musculoskeletal injury, respectively.  Therefore, pre- and post-supplementation data 
resulted in 25 men and 24 women (Table 1).  All subjects completed a health history 
questionnaire containing a brief survey to quantify each participant’s physical activity 
and supplementation status.  None of the participants reported any current or ongoing 
musculoskeletal injury at the time of initiation.  Participants were asked to refrain from 
caffeine, alcohol, analegesics (asprin, acetaminophen, non-steroidal anti-inflammatories, 
and glucoceroticoids) and cigarettes prior to testing weeks and specifically 48-hours prior 
to the oxidative stress run.  All participants were moderately trained, engaging in 3-7 
days per week of aerobic, resistance or recreational activities, but were not highly trained 
competitive athletes.  This study was approved by the University’s Institutional Review 
Board for Human subject and all subjects completed a written informed consent form 
(Appendix A).  Using the procedures described by Howell et al [53]  for estimating 
samples sizes for repeated measures designs, a minimum sample size of n=12 was 
required for each group to reach a statistical power (1-β) of 0.80 based on the findings of 
Derave et al. [30], Stout et al. [102], and Hill et al. [47].  A sample size of n=13 per group 





 A randomized, placebo controlled, mixed factorial design [acute (0 vs. IP vs. 2h 
vs. 4h) × chronic (pre- vs. post-supplementation) × treatment (beta-alanine vs. placebo) × 
sex (male vs. female)] was used to examine the effects of beta-alanine loading on 
markers of oxidative stress.  All other performance variables were assed using separate 
two-way mixed factorial models (time × treatment).  Each participant visited the 
laboratory four times to undergo pre- and post-testing, plus an additional visit to monitor 
supplement compliance.  During week 1 of pre-testing, participants completed an initial 
run to establish their maximal oxygen consumption (VO2max) and to determine the peak 
velocity (PV).  Within two to three days, participants returned to the lab for baseline 
blood draws followed by a non-damaging treadmill run for 40 minutes at 70% PV [75].  
Additional blood samples were drawn immediately post (IP), two hours (2h) and four 
hours (4h) following completion of the run.  All samples were centrifuged and stored 
immediately.  Hydration status was measured and controlled for, using handheld specific 
gravity (VEE GEE Refractometers, Model CLX-1), before the oxidative stress run to 
decrease the risk of hydration and any potential impact on performance.  Each participant 
was randomly assigned to either a placebo (PL; 800 mg/tablet of maltodextrin; 2 tablets 3 
times daily) or beta-alanine (BA; 800 mg/tablet; 2 tablets 3 times daily; CarnoSyn
®
, 
Natural Alternatives Inc, San Marcos, CA) supplementing group, following the 40 minute 
run, for the remainder of the study.  Participants were required to visit the lab after two 
weeks of supplementation to report product intake, any side effects and return completed 
dietary recalls.  Following twenty-eight days of supplementation, participants returned to 
the lab for post-testing consisting of the same pre-testing assessments (VO2max, 40 min 





To control for the effect of previous dietary antioxidant levels on the outcome measures 
of the study, and to establish similar levels of macronutrient and antioxidant intake, 
participants were asked to complete a 3-day dietary recall prior to pre-testing and at the 
beginning of post-testing, consuming the same macro and micronutrient intake before the 
oxidative stress testing. 
Variables 
 The independent variables included: (a) treatment [beta-alanine vs. placebo], (b) 
acute [baseline vs. IP vs. 2h vs. 4h], (c) chronic [week 1 vs. week 7] and (d) sex [male vs. 
female].  The dependent variables measured include: (a) maximal oxygen consumption 
(VO2max), (b) time to exhaustion during VO2max (VO2TTE), and (c) oxidative stress 
markers [total antioxidant capacity (TAC), superoxide dismutase (SOD), isoprostanes (8-
isoprostane), and reduced glutathione (GSH). 
 
Instrumentation 
 Open circuit spirometery (True One 2400® Metabolic Measurement 
System, Parvo-Medics Inc., Sandy, UT) was used to determine maximal 
oxygen consumption (VO2max). 
 A high-speed treadmill (Woodway, Pro Series, Waukesha, WI) was used 
for determination of VO2max, as well as to induce oxidative stress. 
 Handheld specific gravity (VEE GEE Refractometers, Model CLX-1) was 
used to measure hydration. 
 Wavelengths for the TAC, SOD, GSH, and 8-isoprostanes were measured 





Pre- and Post-testing Procedures 
Determination of VO2max 
All participants performed a graded exercise test (GXT) to volitional exhaustion on a 
treadmill (Woodway, Pro Series, Waukesha, WI) to determine VO2max.  Based on the 
protocol of Peake et al [43], the initial GXT velocity was set at 10 km·h
-1
at a 0% grade 
and increased 2 km·h
-1
 every two minutes up to 16 km·h
-1
, followed by 1 km·h
-1
 
increments per minute up to 18 km·h
-1
.  The gradient then increase by 2% each minute 
until VO2max was achieved.  Open-circuit spirometry was used to estimate VO2max 
(l·min
-1
) with a metabolic cart (True One 2400® Metabolic Measurement System, Parvo-
Medics Inc., Sandy, UT) by sampling and analyzing the breath-by-breath expired gases.  
The metabolic cart software calculates VO2 and determines the VO2max value for each 
GXT.  The highest velocity achieved was recorded as peak velocity (PV).  
Exercise Test (Oxidative Stress Run) 
During the experimental protocol, each subject ran the treadmill at a velocity 
corresponding to 70%-75% of their previously determined PV for 40 minutes.  This 
exercise protocol was chosen because it has been shown to induce oxidative stress 
without eliciting muscle damage [2, 12].  Heart rate and rating of perceived exertion 
(RPE) were monitored for intensity.  If heart rate reached ‘near-maximal’ the velocity 
was lowered accordingly.  Changes in velocity and total distance were recorded.  Post-
testing runs were completed at the same velocities as the pre-testing, with no differences 
over time (p=0.112-0.259) or between groups (0.563) in total distance run. 
Blood Collection 
Blood samples were collected prior to the exercise test, immediately following and 2h 
and 4h post-exercise by a person trained in phlebotomy.  Plasma and whole blood 
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samples were obtained via vacutainers, gently inverted ten consecutive times and 





Total Antioxidant Capacity (TAC)  
The antioxidant capacity (mM) was analyzed using a commercial colorimetric assay 
(Catalog # 709001, Cayman Chemical, Ann Arbor, MI) using the oxidation of 2,2’-
Azino-di-[3-ethylbenzthiazoline sulphonate] by metmyoglobin in plasma.  After a five-
fold dilution of the sample, 10 μl of metamyoblobin, 150 μl of chromogen were added, 
followed by 40 μl of hydrogen peroxide to initiate the reaction.    The plate was covered 
and incubated on an orbital plate shaker for five minutes and the absorbance was read at a 
wavelength of 405 nm using a Micro Plate Reader (Model #680, Bio Rad, Hercules, CA).  
Standard curves were generated for all measures using commercially developed standards 
with reported mean r values of 0.81 ± 0.14. 
Superoxide Dismutase (SOD) 
Using a commercial assay kit (Catalog # 706002,Cayman Chemical, Ann Arbor, MI) 
which utilizes a tetrazolium salt was used to detect superoxide radical generated by 
xanthine oxidase and hypoxanthine and measures three types of SOD (Cu/Zn, Mn, and 
FeSOD).  According to the manufacturer’s procedures, 200 µl of diluted radical detector 
and 10 µl of standard was added to designated wells.  The diluted radical detector (200 
µl) and 10 µl of sample (diluted five-fold) was added to the wells.  20 µl of diluted 
xanthine oxidase was added to all the wells to initiate the reactions and the plates were 
then shaken for mixing purposes and covered, on an oribital shaker for 20 minutes.  The 
absorbance of the samples was measured using a micro plate reader (Model #680, Bio 
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Rad, Hercules, CA) at a wavelength of 450 nm.  The precision of this assay previously 
resulted in an intra-assay coefficient of variation of 3.2% and the dynamic range of the kit 
is reported at 0.025-0.25 units/ml SOD.  Standard curves were generated for all measures 
using commercially developed standards, reporting a mean r value of 0.85 ± 0.14.  Intra-
assay coefficients of variation for each assay were determined from each duplicate for all 
participants and resulted in a mean value of 7.07% ± 8.41%. 
Lipid Peroxidation (8-isoprostane) 
The analysis of lipid peroxidation by way of 8-isoprostane was conducted using a 
commercial EIA assay kit (Catalog # 516351.1, Cayman Chemical, Ann Arbor, MI) 
based on the competition between 9-isoprostane and an 8-isoprostane 
acetylcholinesterase (AChE) conjugate. The competitive binding yields an enzymatic 
reaction which can be measured spectrophotometrically.  In short, 100 µl EIA buffer was 
added to non-specific binding (NSB) wells and 50 µl EIA buffer was added to Maximum 
Binding (B0) wells. 50 µl of the 8-isoprostane EIA standard was added to the standard 
wells in order from lowest to highest using the same pipette tip.  Subsequently, 50 µl of 
sample was added to each well, in duplicate.  An additional 50 µl of 8-isoprostane AChE 
Tracer was added to all wells, excluding the Total Activity (TA) and Blank (Blk) wells.  
Also, 50 µl of 8-isoprostane EIA Antiserum was added in the same manner to all wells, 
except the TA, NSB and Blk wells.  Each plate was then covered and incubated for 18 
hours at 4˚C.  Following incubation the wells were emptied and rinsed five times with 
Wash Buffer.  200 µl of Ellman’s Reagent (Catalog # 400050) was added to each well 
and 5 µl of tracer was added to the TA wells.  The plate was covered, secured on an 
orbital shaker in a dark room for 90-120 minutes.  Absorbance of the plate was measured 
at a wavelength 405 nm (Micro Plate Reader Model #680, Bio Rad, Hercules, CA).  
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Intra-assay coefficient of variations were determined at multiple points on the standard 
curve yielding mean coefficients of 12.48% ± 12.3% and an average r value of 0.984 ± 
0.01.  
Glutathione (GSH)  
GSH were analyzed according to procedures from a commercial assay kit (Catalog 
#703002, Cayman Chemical, Ann Arbor, MI).  Fifty µL of standard was added to the 
designated wells, followed by an additional 50 µL of sample to each of the wells.  150 µL 
of a prepared Assay Cocktail consisting of MES Buffer (11.25 ml), reconstituted 
Cofactor Mixture (0.45 ml) and reconstituted DTNB (0.45 ml), was added to each of the 
wells.  The plate was covered and placed on an orbital shaker, in the dark.  The 
absorbance values were measured at 405-414 nm (Micro Plate Reader, Model #680; Bio 
Rad, Hercules, CA) at twenty five minutes (to estimate GSH in the sample.  Performance 
characteristics of this assay have resulted in an inter-assay coefficient of variation of 
3.6% (n=5) and 1.6% (n=84).  Under the standardized conditions of the assay described 
for this assay, the dynamic range is 0-16 µM GSH and 0-8 µM GSSG.  Standard curves 
were generated for all measures using commercially developed standards, reporting a 
mean r value of 0.994 ± 0.002.  Intra-assay coefficients of variation for each assay were 




Separate four-way mixed factorial ANOVAs [4 × 2 × 2 × 2; acute (base vs. IP vs. 2h vs. 
4h) × chronic (pre- vs. post-) × treatment (placebo vs. beta-alanine) × sex (male vs. 
female)] were used to analyze oxidative stress markers.  Two separate two-way mixed 
factorial ANOVAs [2 × 2; time (pre-supplement vs. post-supplement) × treatment 
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(placebo vs. beta-alanine)] were used to evaluate aerobic performance and time to 
exhaustion data (VO2max, VO2TTE, VT). When appropriate, post-hoc analyses for the 
ANOVA models were performed using lower-order ANOVAs and Bonferroni-corrected 
paired samples t-tests.  An alpha level was set at p≤ 0.05, and all analyses were 
performed using PASW version 18.0 (SPSS, Inc., Chicago, IL). 
In addition, percent change scores were calculated for each participant from pre- 
to post-supplementation.  These percent change scores were average separately for the 
BA and PL groups and 95% confidence intervals were constructed around the mean 
percent change scores.  When the 95% confidence interval included zero, the mean 
percent change score was not statistically different than zero.  Additional independent 
samples t-tests were performed on the delta scores between groups.  Results were 
interpreted using magnitude-based statistics, interpreted using Cohen’s thresholds (<0.1, 
trivial; 0.1-0.3, small; 0.3-0.5, moderate; >0.5, large).[50]  To make inferences on true 
effects of BA on performance and oxidative stress variables, the uncertainty in the effect 
was expressed as 90% confidence limits and the likelihood that the effect represents 
substantial change (harm/ergolytic or benefit/ergogenic).  An effect was reported to be 
unclear if the confidence interval overlapped the thresholds for positive and negative 
substantiveness.  These analyses were calculated using Microsoft Excel (Version 2007, 
Microsoft Corporation; The Microsoft Network, LLC, Richmond, VA) 
     
 
 





Compliance was reviewed from dosing journals and returned product bottles.  All 
participants met the required supplement dosage (3.2 grams daily) and 8% of the 
participants demonstrated mild side effects of paresthesia.  On average, the men dosed 
with 0.06 grams·kg·day
-1
 and the women consumed 0.08 grams·kg·day
-1
 of beta-alanine.  
Aerobic Performance 
Maximal Oxygen Consumption [VO2max (l∙min
-1
)] 
There was no two-way interaction (time × treatment, p=0.728), and no main effect 
for treatment (p=0.681) but there was a main effect for time (p=0.020) for men (Figure 
1A).  The marginal means (collapsed across treatment) increased from pre- to post-testing 
(0.12 ± 0.04 l·min
-1
; p=0.020).  The mean percent change scores indicated that VO2max 
increased following 28-days of beta-alanine supplementation (Figure 1C). 
There was no two-way interaction (time × treatment, p=0.813), and no main effect 
for treatment (p=0.476) but there was a main effect for time (p=0.009) for women (Figure 
1A). The marginal means (collapsed across treatment) increased from pre- to post-testing 
(0.80 ± 0.05 l·min
-1
; p=0.009).  The mean percent change scores indicated a significant 
increase in VO2max for the BA group only (Figure 1D). 
VO2TTE (seconds) 
 There was no two-way interaction (time × treatment, p=0.515), and no main effect 
for treatment (p=0.617), but there was a main effect for time (p=0.018) for men (Figure 
1B).  The marginal means (collapsed across treatment) increased from pre- to post testing 
(19.42 ± 15.20 sec; p=0.018).  The mean percent change scores yielded no significant 
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influence of either treatment on time to exhaustion (Figure 1C).  Evaluation of magnitude 
inferences indicated a possible ergogenic effect of BA on VO2TTE (Table 2). 
There was no two-way interaction (time × treatment, p=0.074), and no main 
effects for time (p=0.962) or treatment (p=0.832) for women (Figure 1B).  The marginal 
means (collapsed across treatment) indicated no significant change over time (-0.33 ± 
1.92 sec; p=0.962).  The mean percent change scores yielded no significant influence of 
either treatment on time to exhaustion (Figure 1D).  Evaluation of magnitude inferences 




There was no two-way interaction (time × treatment, p=0.791), and no main 
effects for time (p=0.088) or treatment (p=0.713) for men (Figure 1A).  There was no 
indication of change for VT in men for either group.  The mean percent change scores 
indicated a significant increase for the BA group only (Figure 1C).   
There was no two-way interaction (time × treatment, p=0.344), and no main 
effects for time (p=0.899) or treatment (p=0.119) for women (Figure 1A).  There were no 
significant changes or differences related to the treatments.  Mean percent change scores 
also demonstrated no change in VT following the treatment period (Figure 1D). 
40 min run 
Heart Rate (bpm) 
There were no three-way (acute × chronic × treatment, p=0.419), two-way (acute 
× chronic, p=0.416), (acute × treatment, p=0.391), (chronic × treatment, p=0.189) 
interactions and no main effects for acute (p=0.642), chronic (p=0.189) or treatment 
(p=0.681) for men (Figure 2A).  Marginal means collapsed across chronic and treatment 
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indicated HR values at 20 and 30 minutes were significantly lower than at 40 minutes 
(p=0.01). The mean percent change scores indicated that the PL group had a significant 
increase in heart rate at all four time points (10, 20, 30, and 40 min).  Additionally, there 
was a significant decrease in heart rate at 40 min for the BA group (Figure 2E).  The 
evaluation of magnitude inferences suggest a possible beneficial effect of BA on the HR 
response to a 40 min run (Table 3). 
There was no three-way interaction (acute × chronic × treatment, p=0.330), no 
two-way interaction (acute × chronic, p=0.519), (acute × treatment, p=0.708) or (chronic 
× treatment, p=0.098), and no main effect for treatment (p=0.187), but there was a main 
effect for acute (p=0.001) for women (Figure 2B).  The marginal means when collapsing 
across (chronic and treatment) demonstrated that heart rate values at 10 minutes were 
significantly lower than at 20 and 40 minutes (p<0.01).  At 20 minutes, heart rate values 
were significantly greater than at 10 minutes and no different from any other time points.  
The mean percent change scores indicated that the PL group had a significant increase in 
heart rate at all four time points (10, 20, 30, and 40 min) (Figure 2F). 
Rating of Perceived Exertion (RPE) 
There were no three-way (acute × chronic × treatment, p=0.072), two-way (acute 
× chronic, p=0.416), (acute × treatment, p=0.652), or (chronic × treatment, p=0.122) 
interactions for men.  Additionally, there were no main effects for chronic (p=0.694) or 
treatment (p=0.446) but there was a main effect for acute (p=0.01) (Figure 2C).  Marginal 
means across the acute trial indicated significant lower RPE levels at 10 minutes than at 
20, 30, and 40 minutes (p=0.01).  RPE increased significantly across all time points 
(p=0.01).  The mean percent change scores revealed a significant decrease in RPE at 40 
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min for the BA group (Figure 4E). Magnitude inferences suggest a likely ergogenic effect 
of BA on ratings of perceived exertion at 20-, 30- and 40 minutes of running (Table 3). 
There was a three-way interaction (acute × chronic × treatment, p=0.036) for RPE 
for women.  There was also a two-way interaction for acute × treatment (p=0.002) and a 
main effect for acute (p=0.001).  The marginal means for acute (collapsed across chronic) 
indicated RPE for the BA group at 10 min was significantly less than 20-40 min and for 
the PL, each time point was significantly lower than the subsequent values.  There was a 
significant difference at 40 minutes between the PL and BA groups (p=0.04).   The mean 
percent change scores revealed a significant decrease in RPE at 30- and 40 minutes for 
the BA group only (Figure 2F). Magnitude inferences suggest a likely ergogenic effect of 
BA on ratings of perceived exertion at 30- and 40 minutes of running (Table 4). 
Oxidative Stress Biomarkers 
Total Antioxidant Capacity 
There was no four-way interaction (acute × chronic × sex × treatment; p=0.955), 
no three-way interaction for acute × chronic × treatment (p=0.701), acute × chronic × sex 
(p=0.122), or acute × sex × treatment (p=0.056); however, there was a significant three-
way interaction for chronic × sex × treatment (p=0.031). No two-way interaction resulted 
for chronic × sex (p=0.378), chronic × treatment (p=0.396), or sex × treatment (p=0.819), 
there was a significant main effect for sex (p=0.027) and a main effect for acute 
(p=0.001).  There was no main effect for treatment (p=0.818). The marginal means for 
chronic (collapsed across sex and treatment) indicated a significant decrease in TAC from 
pre- to post-supplementing (p=0.015). The acute marginal means (collapsed across sex 
and treatment) indicated baseline values were significantly greater than IP (p=0.007), two 
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hour (p=0.041) and four hour values (p=0.001).  There were no other significant acute 
values.  The acute marginal means for sex (collapsed across chronic and treatment) 
indicated men had greater values than women (p=0.027). The mean percent change 
scores for men (Figure 3A) indicated a significant decrease in base and 4h TAC values 
for the BA group only.  The mean percent change scores for women, revealed a 
significant decrease in TAC values for the placebo group only (Figure 3C).  The 
evaluation of magnitude inferences suggested no effect of BA on Base and 4H post TAC 
values (Table 3). 
Superoxide Dismutase 
There was no four-way interaction (acute × chronic × sex × treatment; p=0.905), 
no three-way interaction for acute × chronic × sex (p=0.108), acute × chronic × treatment 
(p=0.683), acute × sex × treatment (p=0.488), chronic × sex × treatment (p=0.249), no 
two-way interactions for acute × chronic (p=0.374), acute × sex (p=0.263), acute × 
treatment (p=0.740), chronic × treatment (p=0.091), sex × treatment (p=0.466), but there 
was an interaction for chronic × sex (p=0.021).  Additionally, there was a main effect for 
acute (p=0.031) and chronic (p=0.001), but no main effect for sex (p=0.862) or treatment 
(p=0.846).  The marginal means for chronic SOD (collapsed across sex and treatment) 
demonstrated a significant decrease from pre- to post-supplement (p=0.001). The 
marginal means for acute, sex and treatment SOD values indicated no significant 
differences (p=0.195-1.0) (Figure 4A).  The mean percent change scores for men (Figure 
4B) indicated a significant decrease in SOD values for both PL and BA group at baseline 
and IP time points.  The mean percent change scores for women revealed a significant 
decrease in SOD values for the BA group only at base, 2H post and 4H post (Figure 4C).  
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The evaluation of magnitude inferences suggested a likely harmful effect of BA on Base, 
IP and 2H post SOD values (Table 3). 
8-Isoprostane 
There was no four-way interaction (acute × chronic × sex × treatment; p=0.334), 
no three-way interaction for acute × chronic × treatment (p=0.142), acute × chronic × sex 
(p=0.743), chronic × sex × treatment (p=0.738), acute × sex × treatment (p=0.463), no 
two-way interactions for acute × sex (p=0.459), acute × treatment (p=0.239), chronic × 
sex (p=0.113), chronic × treatment (p=0.191), acute × chronic (p=0.151) or sex × 
treatment (p=0.386).  There was a main effect for acute (p=0.001) and main effect for 
chronic (p=0.001), but no main effect for sex (p=0.058) or treatment (p=0.569).  The 
marginal means for acute 8-isoprostane values indicated baseline values were 
significantly lower than IP (p=0.001) and greater than two hours post (p=0.034). 
Immediate post values were significantly greater than all time points (p=0.001-0.002).  
Values at two hours post were significantly lower than all time points (p=0.001-0.034).  
Values at four hours post were significantly lower than IP (p=0.002) and greater than two 
hours post (p=0.001).  The marginal means for chronic 8-isoprostane levels indicated a 
significant decrease over time (p=0.001) (Figure 5A).  The mean percent change scores 
for men demonstrated a significant decrease in 8-isoprostane at all time points for the BA 
group and at base, 2- and 4H time points for the PL group (Figure 5B).  For women, the 
mean percent change scores demonstrated the same results (Figure 5C). 
Glutathione (GSH)  
There was no four-way interaction (acute × chronic × sex × treatment; p=0.338), 
no three-way interaction for acute × chronic × treatment (p=0.434), acute × chronic × sex 
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(p=0.923), acute × sex × treatment (p=0.774), chronic × sex × treatment (p=0.069), no 
two-way interaction for acute × sex (p=0.317), acute × treatment (p=0.798), chronic × 
sex (p=0.733), or chronic × treatment (p=0.219), sex × treatment (p=0.618), however, 
there was a significant two-way interaction for acute × chronic (p=0.003), and a main 
effect for acute (p=0.001) and chronic (p=0.001).  There was no main effect for sex 
(p=0.245) or treatment (p=0.266).  The acute marginal means (collapsed across sex and 
treatment) indicated baseline values were significantly greater than IP (p=0.001) and four 
hour values (p=0.005).  IP values were significantly lower than all time points (p<0.001); 
values at two hours post were significantly greater than IP (p=0.001), and four-hour GSH 
values were significantly lower than baseline (p=0.005) but significantly greater than IP 
(p=0.001). The chronic marginal means indicated a significant increase from pre- to post-
supplementing (p=0.001) (Figure 6A).  The mean percent change scores, for the men, 
revealed a significant increase in GSH values for both groups, at all time points, except 
for IP values in the BA group, which indicated no change (Figure 6B).  For women, the 
mean percent change values increased for all time points for the BA group, and increased 
for the PL group at base and 4H post (Figure 8C). The evaluation of magnitude 
inferences suggested a likely beneficial effect of BA on Base and 4H post GSH values 
(Table 3). 
Nutrition & Exercise Status 
Nutrition 
There was no two-way interaction (time × treatment) for calories (p=0.469), 
carbohydrates (p=0.051), fat (p=0.314), protein (p=0.129), or protein quality (histidine; 
63 
 
p=0.130).  Furthermore, there were no significant dietary differences between treatment 
groups before or after supplementing (p=0.155-0.752) for either men or women. 
Exercise Status 
There was a two-way interaction (time × treatment) for exercise duration 
(p=0.004) and a main effect for time (p=0.001) and treatment (p=0.003) for hours of 
exercise.  Dependent samples t-tests indicated a significant decrease in time under 
exercise for both BA (-74.9%) and PL (-42.6%) groups (p=0.001) for men from hours of 
exercise pre-supplementation compared to an average of during-supplementing training 
hours. 
There was no two-way interaction (time × treatment) for exercise duration 
(p=0.346) and no main effect for treatment (p=0.528), but there was a main effect for 
time (p=0.002) for women.  The marginal means (collapsed across treatment) indicated a 
significant decrease in time spent exercising (p=0.001) from pre- to post-supplementing 





 The results of the present study suggest that twenty-eight days of beta-alanine 
supplementation has a slight, but significant (p<0.05), influence on aerobic performance 
while reducing perceived and actual rates of exertion during exercise, in both men and 
women (Figures 1-2) .  Furthermore, the forty-minute protocol used in the present study 
was sufficient to induce oxidative stress.  The markers of oxidative stress, 8-isoprostane 
and GSH, were also improved following beta-alanine supplementation, in both sexes 
(Figures 3-6).  Specifically, lipid peroxidation marker, 8-isoprostane, was reduced for all 
time points, across sexes.  Further, GSH levels were augmented for all time points for 
both men and women, excluding IP values in men. 
 Carnosine’s role in exercise performance has been attributed to its physiological 
buffering abilities.  As a cytoplasmic dipeptide characterized by its imidazole chemical 
group, it lends itself as an intracellular buffer, mirroring the intramuscular physiological 
pH.  By virtue of a pKa of 6.83 and its high concentration in muscle, carnosine is more 
effective at sequestering protons, than either bicarbonate (pKa 6.37) or inorganic 
phosphate (pKa 7.2), the other two major physico-chemical buffers over the 
physiological pH range.[1, 8] However, as a result of the greater concentration of 
carnosine than either bicarbonate or inorganic phosphate in the initial stages of muscle 
contraction, its buffering contribution may be quantitatively more important. [89]  In 
support, numerous studies have demonstrated the ergogenicity of beta-alanine 
supplementation in anaerobic [30, 48, 49, 57, 102, 106, 112] performance, with less 
support in aerobic activities.[30, 56, 98, 102, 112] 
Aerobic Performance (VO2max, TTE, VT) 
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 Evaluation of aerobic performance, with beta-alanine supplementation alone, has 
consistently demonstrated no positive effects on VO2peak measured during graded 
exercise tests.[100, 102, 112]  However, this is the first study to evaluate the effects of 
supplementation alone, on a body-weight supported treadmill run.   Maximal oxygen 
consumption increased over time for men and women in both beta-alanine (+2.64%) and 
placebo groups (+3.37%), with no significant interaction, supporting previous results and 
no influence on VO2max.  Evaluation of the confidence intervals demonstrated an 
increase in VO2max for only the BA group, in both sexes (Figure 1C-1D).  The increase 
in VO2max may be attributed to the improvement in muscle buffering capacity.  Even 
during relatively brief, high-intense exercise bouts, a considerable amount of proton and 
metabolite accumulation can occur.  A greater muscle buffering capacity may yield 
improvements in aerobic capacity by lengthening the capacity of enzymatic reactions, 
such as, creatine kinase, hexokinase, lactate dehydrogenase and most influential, 
glyceraldehyde-3-phosphate-dehydrogenase.[52, 107]  
 Time to exhaustion is a common measure of aerobic capacity that has been 
evaluated during a GXT.  Stout et al. [102] reported a slight, but significant 2.5% 
increase in TTE during a GXT on a cycle ergometer.  The authors attributed these 
improvements to anaerobiosis and greater reliance on intracellular buffering observed 
toward the end of a GXT.  In contrast, Zoeller et al.[112] showed no positive influence of 
BA on TTE.  The present study is in line with Stout et al, demonstrating a non-significant 
3.11% increase for the BA supplementing women compared to a -3.4% decrease in the 
placebo group.  Both male groups demonstrated a significant increase in TTE, at 4.61% 
(BA) and 2.8% (PL).  Although not significant, the magnitude of the increases give 
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further support for the possible beneficial effects of BA supplementation on TTE, for 
both men and women.   
 Increasing skeletal muscle carnosine concentration with BA supplementation may 
improve the ability to stabilize intramuscular pH during intense exercise by buffering 
accumulating H
+
.  Offsetting the indirect effect of proton accumulation on contractile 
function with the use of BA, has been shown to be effective in delaying neuromuscular 
fatigue, improving ventilatory threshold (VT) and time to exhaustion in both trained and 
untrained individuals.[47, 60, 101, 111]  Delaying CO2 by-production, due to a reduced 
reliance on extracellular buffering can stimulate an improvement in VT and delay 
fatigue.[39]  Ventilatory threshold represents the non-linear point at which ventilation 
begins to increase disproportionately with VO2 during a graded exercise test [77] and also 
corresponds to an increase in anaerobic metabolism.[71]  Previous improvements in VT, 
following 28-days of beta-alanine supplementation, have been reported.[100, 102, 112]   
Following a similar supplementation protocol as the current study, Stout et al.[102] 
demonstrated a 13.9% increase in VT in untrained women, while Zoeller et al.[112] 
reported a 7% increase in untrained men.  The current study also demonstrated a 
significant 4.8% increase for the male BA group, and a non-significant 3.0% increase for 
the female BA group compared to a -2.2% decrease in VT for the PL group.     
40 minute Run 
To date, the influence of augmented muscle carnosine levels on longer duration 
exercise has yet to be evaluated.  Beta-alanine has been shown to be ergogenic for short, 
high-intensity work bouts,[4, 29, 90] while single longer duration events have been 
suggested to reflect no improvements, due to a negligible reliance on muscle buffer 
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capacity.  However, there is evidence demonstrating a similar association between lactate 
and H
+
 accumulation during graded exercise test.[99]  Soller et al. [99] reported a 
significant increase in [H
+
] at 50% VO2max in untrained subjects (VO2max: 2.39 ±1.04 
l·min
-1
).   Therefore, the moderate intensity (70%) of the current exercise protocol would 
be sufficient to initiate a lactate and H
+
 response.  Although TTE was pre-determined, 
HR and RPE were recorded to establish exertion.  For men in the current study, the PL 
supplementing group demonstrated a significant increase in HR for all time points 
(Figure 2A), while the BA group showed a significant decrease at 40 min post-
supplementing (Figure 2E). Similarly, the women in the PL group showed a significant 
increase in HR across all time points (Figure 2F).  In addition, RPE followed a similar 
pattern, with only the BA group showing a decreased level of exertion at 40 min and 30 
and 40 min for the men and women, respectively (Figure 2).  In the current study, VT 
increased for both men and women suggesting an enhanced buffering capacity.  
Increasing VT may be associated with improved submaximal performance.  Indeed, the 
subjects in the current study demonstrated a significant decrease in level of exertion. 
Exercise-Induced Oxidative Stress 
Moderate and exhaustive exercise stimulates the increase of ROS production, 
exceeding the capacity of antioxidant defenses.[2, 55, 66]  With an exercised-induced 
depletion of ATP, catabolism of high ADP intracellular levels trigger the conversion of 
xanthine dehydrogenase to xanthine oxidase causes an increase in free radicals. [74] ROS 
concentration may be further elevated due to an increased respiration rate and 
concomitant increased flow of electrons in the electron transport chain.[69]  In addition, 
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ROS formation has been shown to be dependent on pH, while lactate has also been 
shown to scavenge the HO
·
 radical and O2
-
.[93] 
Severin was the first to demonstrate an increase in muscle working capacity when 
carnosine was added to an in vitro exhausted muscle.[96]  Additional experimental in 
vitro evidence provided verification of the detrimental effects of free radicals on altered 
contractile function, decreased maximal force and augmented fatigue rates in animal 
skeletal muscle.  Boldyrev and colleagues [20] have suggested that the antioxidant 
protective effects of carnosine can relieve some of the fatigue induced effects due to its 
binding affinity for reactive species, such as hydroxyl radicals and ROS, therefore 
preventing compounded damage.  Ergov et al. [35] provided further evidence for an 
antioxidant effect of carnosine attributing its ability to quench singlet oxygen molecules 
to its functional imidazole structure.  Kohen et al. suggest that a drop in pH hinders the 
scavenging abilities of histidine-related compounds,[63] however, the high-buffering 
capacity of carnosine allows for a unique antioxidant ability by prolonging physiological 
pH values.[79]  More so, human skeletal muscle holds some of the highest levels of 
carnosine, as a potential physiological adaptation to cope with oxidative stress. The 
hydrophilic structure of carnosine plays a large role in its protective characteristic within 
the cytosol.  High muscle carnosine levels have been found in other tissues, including 
nerve, eye and brain tissue.  With this knowledge, the suggested primary role of 
carnosine as a pH buffer, may be inconsistent with other potential functions in subsidiary 
tissues, such as an antioxidant. 
Total Antioxidant Capacity 
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Multiple studies have reported a significant elevation in TAC following an acute 
bout of exercise.[12, 37, 58, 72]  The resulting increase in TAC following exercise 
suggests an increase in antioxidant defenses, and typically reflects mobilization of tissue 
antioxidant stores into plasma.[37] Antioxidant capacity, an overall sum of all 
antioxidants, may be difficult to interpret because it can increase as a result of numerous 
internal antioxidants, as well as to adaptations in nutrition and/or the adaptablity to a state 
of oxidative stress.[62] 
The current study yielded conflicting results with previous studies, presenting a 
significant reduction in TAC levels, from baseline, remaining suppressed for up to 4H.  
This trend was the same for all groups and genders.  While most studies demonstrate an 
increase in TAC following exercise, the present results could potentially be explained 
from a decreased synthesis of hepatic urate. Uric acid is a specific tissue antioxidant 
product that assists with the mobilization of tissue antioxidants into the plasma, synthesis 
of urate is blunted during periods of acidosis.[25]  This could potentially reduce the 
muscle-plasma antioxidant flux, and if there is a greater suppression of intramuscular 
oxidative markers, there would likely be a reduction in plasma TAC levels.  Chronic 
values demonstrated a slightly greater influx in TAC levels from pre- to post-
supplementation.  Although non-significant, the women revealed a greater increase in 
TAC IP exercise than the PL group, prospectively attributed to a greater muscle buffering 
capacity and simultaneous urate-TAC plasma efflux.  
Superoxide Dismutase 
A single bout of treadmill running and other acute exercise has been shown to 
increase SOD as a result of increased O2
-
,[83] potentially offering greater antioxidant 
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protection.[55]  It was hypothesized that SOD values would increase following exercise 
and return to baseline within the 4H recovery time.  However, while acute values 
increased IP running, SOD levels did not return to normal during the recovery time, and 
the PL group demonstrated a -5% decrease from baseline.  Pepe et al. reported a similar 
non-significant decrease in SOD following various running bouts (800m-3,000m), with 
similar responses for men and women.[80] 
Carnosine has been shown to possess superoxide dismutase activity, in vitro.[43]  
It is important to identify that although plasma markers are a reliable indication of 
oxidative stress, less stable molecules may be completely oxidized within other tissues, 
such as skeletal muscle and other organs and tissues.[81]  It has been shown that many 
reactive species are membrane permeable and have a longer half-life, in particular the 
superoxide anion (O2
-
) rapidly dismutates to H2O2 with a longer half life within the blood 
and plasma.[75]  Consequently, a large decrease in SOD has been attributed to the 
presence of H2O2, which inhibits SOD activity.[14]  That being said, the significant 
decrease in chronic values for both groups, with the BA group showing a greater blunted 
SOD response (Figure 6), may be attributed to the reduced stability and permeability of 
SOD transmission from skeletal muscle to plasma.   Additionally, exercise severely 
increases free radicals, specifically H2O2, production in vascular tissues, that have a 
longer half-life and more permeable to macromolecules within the blood.[75]  This 
attribute may have caused a greater decrease in SOD values over time.  More so, it has 
been suggested that following acute exercise, increased production of ROS could 




Isoprostanes materialize from the oxidation of arachadonic acid, and their 
appearance from strenuous cycling and running is well documented.[36, 108]  Although 
the duration and intensity of previous running protocols differ from the current study, all 
studies demonstrated a significant increase (22-80%) in lipid peroxidation, in the form of 
isoprostanes.[108]  The effects of exercise on blood lipid peroxidation may be heavily 
reliant upon oxygen partial pressure, and therefore increased under more intense hypoxic 
activities.[75]  The present study demonstrated an average 15% increase in IP 8-
isoprostane levels following 40 minutes of running, validating the exercise protocol in the 
current protocol, initiated some degree of oxidative stress.  Results from the present study 
indicate that lipid peroxidation, as measured by 8-isoprostane, was elevated immediately 
returning to near baseline values at 2H post.  This increase likely represents an increased 
oxidation of unsaturated fatty acid, which is supported following aerobic exercise.[108, 
110]  
In vitro, Boldyrev gave substantial support for the role of carnosine in lipid 
peroxidation inhibition, protecting biological membranes.[17]  Furthermore, Kohen et al. 
[63] previously demonstrated a decrease in the oxidation of linoleic acid from carnosine, 
and Salim-Hanna supported this by revealing 53% protection against lipid oxidation at a 
concentration of 10 mM carnosine. [91]  The change in 8-isoprostane levels from pre- to 
post-supplementation suggest a possible decrease in resting lipid peroxidation, as well as 
minimizing oxidative damage IP strenuous exercise. However, additional consideration 
must be given to the decrease in 8-isoprostane levels in the PL group (Figure 7), although 
the response was not as great as the BA group.  This marker has been shown to be fairly 
stable, under freezing conditions and all samples were stored under the same conditions.  
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Furthermore, the prevention of unsaturated fatty acids, within the mitochondria, may 
protect membrane permeability and ion pumps.[82]  Also, maintaining calcium-ATPase 
within the sarcoplasmic reticulum may maintain the integrity of the excitation-contraction 
coupling process in vivo,[17, 34, 95] creating a possible link between carnosine’s ability 
to reduce lipid oxidation and potential improvements in performance. 
Glutathione 
The most frequently used antioxidant marker of exercise-induced oxidative stress 
is the glutathione redox status, which demonstrates a decreased ratio following 
exercise.[38, 55, 108]  In the current study, due to the purification of the samples and the 
assay technique, only reduced glutathione (GSH) was measured.  The exercise protocol in 
the current study initiated a decrease in GSH values, which is consistent with other 
exercise protocols.  In fact, Gopal et al. [42] instituted a duplicate protocol to the current 
study, running for 30 minutes at 75%-80% VO2max, reporting a significant decrease in 
GSH.   Glutathione levels IP exercise significantly decreased (p<0.05) and approached 
near baseline levels at 4H, however, remained statistically different (p=0.01).  This study 
provides more data on the timing of GSH analysis, showing that GSH levels remain 
depressed at 4H and 5H, [72] but return to baseline at 6H.[13]   The decrease in GSH 
following intense exercise reflects an increased consumption by muscle as well as a lag in 
hepatic GSH supply pulling thiols from the blood supply.[72]  
High levels of carnosine have been found in the lens of the human eye, in addition 
to high glutathione levels. These elevated optic levels have been attributed to protective 
characteristics with anti-inflammatory, wound healing, and cataract diminishing 
effects.[17]  The differences between optic and skeletal muscle physiology are evident, 
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although the relationship between carnosine’s antioxidant effects in both are uncertain.  
Carnosine has been shown to reduce peroxidation processes and GSH within the lens, 
decreasing cataracts.[19, 61]  The only in vitro data with carnosine is related to cataract 
processes.  The present in vivo results demonstrate a significant elevation in chronic GSH 
values (p<0.05).  Although there were no significant gender effects, the women BA group 
had a more prominent response, significantly increasing GSH values at all time points, 
post-supplementation (Figure 6A).  This increase in GSH following supplementation may 
signify free radical scavenging abilities within the muscle.  
Limitations 
 Plasma levels of antioxidant markers and enzymes, which was the site of markers 
in the current study, may represent a redistribution between tissue and plasma.[55]  While 
the majority of literature interprets blood and muscle antioxidant markers in tandem, and 
it is reasonable to assume there is bidirectional movement across membranes, the half-life 
and permeability of specific enzymes and markers may need further interpretation.  All 
previous antioxidant research with carnosine has been done in vitro or in vivo mouse 
models, lacking carnosinase.  Therefore a strict interpretation of available literature must 
be viewed with caution.  However, markers with greater stability and trans-tissue 
permeability may provide insight. Stable lipid oxidative markers, and possibly GSH may 
provide the most valuable perspective of the antioxidant capabilities of carnosine in 
humans.  Future research should re-evaluate these markers in a more controlled 
population.  The alterations in time under training could have potentially influenced some 
of the more sensitive markers (SOD, TAC), due to the various reported effects of training 
status on oxidative stress.[2, 11]  A further limitation is a result of the subject sample.  
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Several studies have used a similar cohort of moderately trained men and women; 
however, the PL group in the current study resulted in some similar, if not better, 
adaptations than the BA group.  The presence of this potential confounder is beyond the 
control of the investigators. It is important to discuss the change in exercise status from 
the beginning to the end of the supplementation period.  Both men and women 
demonstrated a reduction in time under training from pre- to post-supplementation.  
Specifically, there was a significant decrease for men (-75%, -43%) and women (-70%, -
57%) for the BA and PL groups, respectively.  Despite the reduction in training time, 
there could be a potential influence of BA supplementation to help maintain aerobic 
capacity under periods of reduced training, demonstrated by an increase in VO2max in 
the current study.  Maximum oxygen uptake and TTE during a GXT has not been shown 
to reflect a detraining effect in several studies,[26, 51, 68] which is supported by the 
current study.  However, HR may be a better indication of detraining.[26]  While both 
BA groups yielded greater reductions in pre-post training durations [-70%-75% (BA) vs. 
-43%-57% (PL)], only the PL groups revealed a significant increase in HR.  This may 
demonstrate a slight influence of BA supplementation minimizing the effects of 
detraining. 
An additional limitation was the lack of direct carnosine measurements.  Although 
muscle carnosine concentration was not measured directly, several recent studies have 
shown significantly elevated carnosine levels (+60%) after 28 days of BA 
supplementation.[46, 47]  Furthermore, the dosing strategy was similar to those used in 
the studies of Harris et al.[46] and Hill et al.[47] at 3 g-6 g per day (126 g given the first 
21 days and 63 g given over the second set of 21 days), suggesting that muscle carnosine 
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levels were increased. Dosing recommendations for beta-alanine are somewhat broad and 
generalized, recommended in absolute amounts from 6 grams per day, in divided doses 
for a loading phase, to 3 grams per day for maintenance, for all individuals, independent 
of age, height, weight and sex.  The present study utilized the time release formula at 4.8 
grams daily in divided doses (CarnoSyn
®
, Natural Alternatives Inc, San Marcos, CA) 
which has been demonstrated to significantly augment muscle carnosine levels by 27-
39% in fast- and slow-twitch muscle fibers, respectively [6] under a similar dosing 
scenario.   When evaluating dosage on a per kg basis, men consumed an average intake of 
0.06 grams·kg·day
-1
, while women consumed an average of 0.08 grams·kg·day
-1
.  
Additionally, there were no significant correlations between body weight dosing and all 
variables (p=0.179-0.954).  While the current study and previous reviews support the 
ergogenicity of a generalized supplementation regime,[4, 10, 29, 46, 90] future 
recommendations should evaluate the physiological effects of body weight specific 
consumption of  beta-alanine on both carnosine augmentation, performance and oxidative 
stress.   
Conclusions/Practical Applications 
In a large number of studies, antioxidant supplementation has not been shown to 
be directly ergogenic on performance variables.[23, 64]  Beta-alanine on the other hand 
has substantial support for its role in anaerobic performance, training volume, and body 
composition.  The current study adds to the ergogenic effect, demonstrating increases in 
VT, as well as a potential increase in VO2max.  This is the first study to report 
quantitative evidence for a feeling of reduced effort during exercise, giving a foundation 
for use in both aerobic and anaerobic activities (Figure 2).  Future research should further 
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evaluate feelings of reduced efforts during various exercise environments, as well as the 
influence of BA on maintaining training adaptations during a period of detraining. 
 A biological antioxidant is characterized by its abilities to prevent oxidative 
damage to lipids, proteins, DNA and other macromolecules.[62]  There is some 
specificity, in that most antioxidants provide only one type of protection.  The present 
results are consistent with the physiological role for carnosine, demonstrated in vitro.[82]  
Our data suggest that carnosine, in vivo, may have an influence on attenuating lipid 
peroxidation and thus protecting biological membranes.  Although there is still much to 
be elucidated with the chronic attenuation of lipid peroxidation, this study gives insight 
into potential clinical and therapeutic uses.  Our data, along with previous human and 
animal studies, suggest three possible mechanisms that carnosine may attenuate exercise 
induced oxidative stress: 1) regulating the accumulation of H
+
, thereby controlling pH 
(indirectly reducing oxidative stress); 2) serving as a scavenger of free radicals, and 
indirectly maintaining stability of the cell membrane and enzyme integrity; and 3) a 
potential influence on augmenting calcium kinetics by maintaining contraction-induced 
muscular fatigue, although this has not yet been evaluated in vivo. 
Additionally, as a secondary variable the question of gender based oxidative 
responses to exercise are not completely evident.  As hypothesized, there were no 
significant gender differences for SOD, isoprostanes or GSH.  In contrast, there was a 
significant difference between men and women for TAC values.  While this study is 
original in its approach to evaluate the antioxidant effects of BA supplementation in men 
and women, the results provide a foundation for future research examining other markers 
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of oxidative stress localized within the skeletal muscle, as well as chronic effects on 
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1.       Complete informed consent and health and exercise status questionnaire.











Heart rate @ every 10 minutes
RPE @ every 10 minutes
Distance recorded
Blood Draw IP
Standard Food (Gatorade + Harvest Energy Bar)
2H Post Blood Draw
4H Post Blood Draw
-1 male lost due to injury @ pre-test -1 female lost due to injury @ pre-test
-1 male excluded from 40-min run to due scheduling -1 female lost due to inability to finish 40 min run
BA (n=12) PL (n=13) BA (n=13) PL (n=11)
Post-testing
Repeat steps 1 & 2 above.
Women (n=24)
36 hour rest (minimum)
Random Assignment to Groups

























BA - VO2 
(M; F)
PL - VO2 
(M;F)
BA - VT (M; 
F)





















































































































































































































































    















































































































   




















































































































































































































































































































Table 1. Demographic characteristics for men and women. 
  
Age (yrs) Height (cm) Weight (kg) VO2max (l·min
-1
) 
Men (n=26) 22.0 ± 3.3 177.8 ± 5.5 79.0 ± 9.7 3.9 ± 0.5 






















Table 2.  Effect of beta-alanine supplementation on maximal oxygen consumption 
(VO2max), time to exhaustion during a graded exercise test (VO2TTE) and ventilatory 

















VO2max 0.83, ±4.2 55.3 % 15.0 % 29.8 %
VO2TTE 2, ±4.5 71.6 % 10.9 % 17.4 %
VT -0.36, ±12 49.2 % 5.5 % 45.2 %
VO2max 0.28, ±7.7 45.7 % 19.3 % 35.0 %
VO2TTE 6.6, ±7.7 96.0 % 1.8 % 2.2 %



















Table 3. Effect of beta-alanine supplementation on heart rate (HR) and ratings of 
perceived exertion (RPE) at 10, 20, 30 and 40 minutes and qualitative practical 












HR10 -5.7, ±7.7 99.4 % 0.5 % 0.2 %
HR20 -5.3, ±3 99.4 % 0.4 % 0.2 %
HR30 -8.4, ±7.7 99.8 % 0.1 % 0.1 %
HR40 -6.8, ±3.4 99.8 % 0.1 % 0.1 %
RPE10 2.7, ±7.7 29.2 % 6.2 % 64.6 %
RPE20 -6.6, ±8.1 89.6 % 3.1 % 7.2 %
RPE30 -9.8, ±7.7 96.1 % 1.3 % 2.7 %
RPE40 -11, ±10 96.4 % 1.0 % 2.6 %
HR10 0.63, ±7.7 52.7 % 20.4 % 26.9 %
HR20 0.06, ±3.6 41.6 % 19.0 % 39.4 %
HR30 -2.8, ±7.7 77.5 % 8.5 % 14.0 %
HR40 0.48, ±3.9 33.6 % 16.8 % 49.7 %
RPE10 0.6, ±7.7 42.1 % 7.2 % 50.7 %
RPE20 -4.8, ±9.8 76.7 % 4.8 % 18.4 %
RPE30 -9.9, ±7.7 94.0 % 1.6 % 4.3 %





























Table 4. Effect of beta-alanine supplementation on oxidative stress markers measured as 
total antioxidant capacity (TAC), superoxide dismutase (SOD), 8-isoprostanes (8-ISO), 
glutathione (GSH) and the qualitative practical significance for the entire group (A), men 






TAC Base -54, ±40 1.3 % 0.1 % 98.6 %
IP 2, ±44 52.2 % 1.5 % 46.2 %
2H 23, ±45 79.7 % 1.0 % 19.2 %
4H 9.9, ±14 87.2 % 2.3 % 10.5 %
SOD Base: 13 ±25 80.6 % 1.8 % 17.6 %
IP 27, ±15 99.7 % 0.1 % 0.3 %
2H 13, ±11 95.9 % 1.1 % 3.0 %
4H -8.6, ±14 14.4 % 2.8 % 82.9 %
8-ISO Base -5.3, ±30 60.7 % 2.1 % 37.1 %
IP 8, ±24 27.5 % 2.4 % 70.1 %
2H 25, ±50 12.2 % 0.7 % 87.2 %
4H 5.2, ±25 35.4 % 2.5 % 62.2 %
GSH Base -3.2 ±9.9 26.8 % 5.8 % 67.4 %
IP 4.1 ±19 62.6 % 3.3 % 34.1 %
2H -0.98, ±12 42.0 % 5.4 % 52.6 %
4H -8.5, ±14 14.4 % 2.8 % 82.8 %
Mean improvement 


















TAC Base -89, ±54 0.5 % 0.0 % 99.5 %
IP -34, ±62 17.8 % 0.7 % 81.6 %
2H 36, ±90 75.1 % 0.6 % 24.4 %
4H -6.5, ±20 27.6 % 2.9 % 69.5 %
SOD Base: 20 ±17 96.8 % 0.6 % 2.6 %
IP 31, ±22 98.6 % 0.2 % 1.1 %
2H 18, ±12 99.1 % 0.3 % 0.7 %
4H -11, ±18 15.2 % 2.2 % 82.6 %
8-ISO Base -5.3, ±7.7 60.7 % 2.1 % 37.1 %
IP 8, ±24 70.1 % 2.4 % 27.5 %
2H 25, ±7.7 87.0 % 0.9 % 12.0 %
4H 5.2, ±25 62.2 % 2.5 % 35.4 %
GSH Base -9.7 ±12 7.2 % 2.1 % 90.8 %
IP -19 ±25 9.1 % 1.1 % 89.8 %
2H -11, ±22 19.6 % 2.2 % 78.2 %















































TAC Base -19, ±57 28.2 % 1.0 % 70.8 %
IP 39, ±64 84.6 % 0.6 % 14.8 %
2H 12, ±21 83.0 % 1.9 % 15.1 %
4H 25, ±19 98.0 % 0.3 % 1.7 %
SOD Base: 6.8, ±13 79.6 % 3.5 % 17.0 %
IP 23, ±24 94.0 % 0.7 % 5.3 %
2H 9.5, ±20 77.6 % 2.4 % 20.0 %
4H -5.2, ±23 33.6 % 2.7 % 63.7 %
8-ISO Base -1.8, ±46 51.9 % 1.5 % 46.6 %
IP 11, ±30 25.9 % 1.8 % 72.3 %
2H 28, ±61 21.9 % 0.8 % 77.2 %
4H 2.1, ±38 52.8 % 1.8 % 45.5 %
GSH Base 4.3 ±17 65.2 % 3.7 % 31.2 %
IP 28, ±28 94.8 % 0.6 % 4.6 %
2H 7.2, ±14 79.1 % 3.2 % 17.7 %




























Appendix  D. 
Figure Legends 
Figure 1.  Marginal means for aerobic capacity for (A) maximal oxygen consumption 
(VO2max) and ventilatory threshold (VT) for pre- to post-supplementation for men and 
women, (B) time to exhaustion during the GXT (VO2TTE).  Mean percent change scores 
from pre- to post-supplementation with 95% confidence intervals for VO2max, VO2TTE, 
VT for men (C) and women (D) for the beta-alanine [BA; black] and placebo [PL; 
shaded] groups.  
(A) * indicates a significant increase from pre- to post-supplementation (p<0.05).  
Values are marginal means ± SEM. 
(B) * indicates a significant increase from pre- to post-supplementation (p<0.05).  
Values are marginal means ± SEM. 
(C) * indicates the percent change for VO2max and VT was significantly greater than 
zero (p<0.05).  Values are means ± 95% confidence intervals. 
(D) * indicates the percent change for VO2max was significantly greater than zero 
(p<0.05).  Values are means ± 95% confidence intervals. 
Figure 2.  Marginal means for heart rate for men (A) and women (B) and marginal means 
for ratings of perceived exertion for men (C) and women (D) taken at time intervals of 10 
minutes (1), 20 minutes (2), 30 minutes (3) and 40 minutes (4) during the oxidative stress 
run.  Mean percent change scores from pre- to post-supplementation with 95% 
confidence intervals for HR (Black) and RPE (Shaded) for men (E) and women (F) for 
the beta-alanine (BA; square) and placebo (PL; circle) groups. 
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(A) * indicates a significant difference between values (p<0.05).  Values are marginal 
means. 
(B) * indicates a significant difference between values (p<0.05).  Values are marginal 
means. 
(C) * indicates a significant difference between values (p<0.05).  Values are marginal 
means. 
(D) * indicates a significant difference between values (p<0.05).  † indicates a 
significant difference between groups (p<0.05). Values are marginal means. 
(E) * indicates the percent change for placebo HR was significantly greater than zero 
at all time points (p<0.05). † indicates the percent change for HR and RPE at 40 
minutes was significantly less than zero (p<0.05).Values are means ± 95% 
confidence intervals. 
(F) * indicates the percent change for placebo HR was significantly greater than zero 
at all time points (p<0.05). † indicates the percent change for RPE at 30 and 40 
minutes was significantly less than zero (p<0.05).Values are means ± 95% 
confidence intervals. 
Figure 3.  Marginal means for (A) total antioxidant capacity (TAC) from pre- to post-
supplementation for beta-alanine (black) and placebo (shaded).  Values are marginal 
means.  Mean percent change scores from pre- to post-supplementation with 95% 
confidence intervals for men (B) and women (C). 




(B) * indicates the percent change for baseline and 4H TAC values were significantly 
less than zero (p<0.05).  Values are means ± 95% confidence intervals. 
(C) * indicates the percent change for baseline TAC values were significantly less 
than zero (p<0.05).  Values are means ± 95% confidence intervals. 
Figure 4.  Marginal means for (A) superoxide dismutase (SOD) from pre-to post-
supplementation for beta-alanine (black) and placebo (shaded) groups.  Values are 
marginal means.  Mean percent change scores from pre-to post-supplementation with 
95% confidence intervals for men (B) and women (C). 
(A) * indicates a significant difference between values (p<0.05).  Values are marginal 
means. 
(B) * indicates the percent change for baseline and IP SOD values were significantly 
less than zero (p<0.05).  Values are means ± 95% confidence intervals. 
(C) * indicates the percent change for baseline, 2H and 4H SOD values were 
significantly less than zero (p<0.05).  Values are means ± 95% confidence 
intervals. 
Figure 5.  Marginal means for (A) 8-isoprostanes (8ISO) from pre-to post-
supplementation for beta-alanine (black) and placebo (shaded) groups.  Values are 
marginal means.  Mean percent change scores from pre-to post-supplementation with 
95% confidence intervals for men (B) and women (C). 
(A) * indicates a significant lower value between all time points (p<0.01).  † indicates 
a significant greater value than all time points (p<0.01). †† indicates a significant 
decrease over time (p<0.01).  Values are marginal means. 
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(B) * indicates the percent change for all time points for 8ISO values were 
significantly less than zero (p<0.05).  Values are means ± 95% confidence 
intervals. 
(C) * indicates the percent change for all time points for 8ISO values were 
significantly less than zero (p<0.05).  Values are means ± 95% confidence 
intervals. 
Figure 6.  Marginal means for (A) glutathione (GSH) from pre-to post-supplementation 
for beta-alanine (black) and placebo (shaded) groups.  Values are marginal means.  Mean 
percent change scores from pre-to post-supplementation with 95% confidence intervals 
for men (B) and women (C). 
(A) * indicates a significant lower value between all time points (p<0.01).  † indicates 
a significant greater value than IP and 4H values (p<0.01). Values are marginal 
means. 
(B) * indicates the percent change for all time points for GSH values were 
significantly greater than zero (p<0.05).  Values are means ± 95% confidence 
intervals. 
(C) * indicates the percent change for all time points for GSH values were 
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 Consent Form 
University of Oklahoma Health Sciences Center (OUHSC)  
University of Oklahoma, Norman Campus 
 
The antioxidant effects of a non-essential amino acid, beta-alanine, on oxidative stress 
in men and women 
 
Dr. Jeffrey R. Stout 
 
This is a research study. Research studies involve only individuals who choose to 
participate. Please take your time to make your decision. Discuss this with your family 
and friends. 
 
Why Have I Been Asked To Participate In This Study? 
You are being asked to take part in this trial/study because you are a healthy, 
moderately active man or woman between the ages of 18-35.   
 
Why Is This Study Being Done? 
The purpose of this study is to evaluate the effect of beta-alanine, compared to a 
placebo (an inactive substance) on the acute effects of exercise on the body. 
 
What is the Status of the Drugs (Devices or Procedures) involved in this study? 
Beta-Alanine is a naturally occurring amino acid produced in the liver and in muscle 
tissue as a component of carnosine.  It is found in common meats such as turkey and 
chicken.  The total amount that you might consume in this study is comparable to 150 
grams of chicken breast (i.e. about 4 chicken breasts).  The placebo tablets are made up 
of maltodextrin, a sweet starch used as a common additive, containing fewer calories than 
sugar.  Total daily consumption would be ~4-8 grams totaling 24 calories per day. 
The supplement in this study has not been evaluated or approved by the US Food and 
Drug Administration.  Beta-Alanine is characterized by the food and Drug 
Administration as Generally Regarded as Safe (GRAS).  The use of this supplement is 
considered investigational and not intended to diagnose, treat, cure, or prevent any 
disease. 
 
How Many People Will Take Part In The Study? 
About 72 people will take part in this study, all at this location. 
 
What Is Involved In The Study? 
110 
 
If you agree to be in this study, you will be asked to do the following: 
1. Fill out an ENROLLMENT FORM and a PRE-EXERCISE TESTING HEALTH and 
EXERCISE STATUS QUESTIONNAIRE, which may determine your ability to 
participate in this study. 
2. Complete the entire study, including the pre-testing (Week 1- Visits 1, 2, and 3), the 
supplementing period at home (Weeks 2-5) and post-testing (Week 6; Visits 4, 5, and 
6). 
3. Abstain from caffeine, supplements, multi-vitamin and anti-inflammatories during 
the two weeks of testing and maintain your current exercise routine through the 
duration of the study. 
4. During Visits 1 (Week 1) and 4 (Week 6) you will be tested for cardiorespiratory 
fitness (VO2max).  You will be required to run on a treadmill with a mouthpiece 
attached to your head and wear a heart rate monitor, for 7-15 minutes.  Difficulty 
level and speed of running will increase every 2 minutes.  You will be required to run 
until you can no longer comfortably keep up with the treadmill. 
5. Within 24-48 hours of your VO2max test, during Visits 2 (Week 1) and 5 (Week 6) 
you will be asked to perform a critical velocity test by completing three runs to 
exhaustion on a treadmill. The intensities of the three runs will be based on you 
initial fitness level at 110% and 90% and 100% of your final velocity achieved 
during the VO2max test.  Each run will last between 1 and 15 minutes, with at least 
15 minutes of recovery between each of the runs.  Your finger will also be pricked 
before and after each run to measure lactate levels.  This prick is small and does not 
require a band-aid. 
6. During Visits 3 (Week 1) and 6 (Week 6) occurring 24-48 hours after the previous 
visit, you will also be asked to perform a submaximal run on a treadmill for 40-45 
minutes at 70-75% of your final velocity achieved during the VO2max test.  Your 
hydration levels will be assessed prior to your run with a urine sample, in order to 
prevent dehydration.  You will also have your blood drawn before, immediately after, 
2 hours after and 4 hours after your run. 
7. During Week 1 you will be asked to write down what you eat for three total days.  
You will be asked to eat a similar diet during Week 6 in order to keep your vitamin 
and mineral intake similar between weeks.   
8. Following Visit 3 you will be randomly assigned to a supplement group with either 
beta-alanine (2 capsules of 800 mg Beta-Alanine, 3 times daily) or placebo (2 
capsules of 800 mg Maltodextrin (a common starch), 3 times daily).  This assignment 
will be random and neither you nor the investigator will know which supplement you 
are assigned to.  You will consume the product three times a day for 28 days orally.  
You will also be asked to record your consumption on a provided supplement log. 
9. Post-testing (Visits 4, 5, and 6) will occur following consumption of all of your study 
product. 
 
For Randomized Trials: 
You will be randomized to receive either study supplement (a non-essential amino acid, 
Beta-Alanine) or placebo (inactive substance, which will look like the study drug). 
Randomization means that you are put in a group by chance. If you have an equal; 50/50 
chance use the following comparison, like the flip of a coin.  A computer program at the 
study sponsor will make this random assignment. Neither you nor the investigator will 
choose which group you will be in.  Also, neither you nor the investigator will know 




How Long Will I Be In The Study? 
We think that you will be in the study for a total of six weeks with a total of 6 lab 
testing visits. There will be a set of three pre-testing days, followed by 28 days (about 
four weeks) of consuming your assigned supplement, and three post-testing days after 
consumption of all of your assigned supplement. You will also be required to visit the lab 
one time per week during the supplementation period to submit your supplement log (for 
a total of 4 times).  
There may be anticipated circumstances under which your participation may be 
terminated by the investigator without regard to your consent. The investigators may 
terminate your participation if you fail to follow the pre-testing instructions (i.e. consume 
caffeine and anti-inflammatories prior to testing) and if you fail to consume your 
assigned supplement. 
 
What Are The Risks of The Study?  
There is minimal risk from consumption of beta-alanine, a flushing/tingling of the skin 
may occur.  This flushing/tingling has not been reported with the time-release form of 
beta-alanine that is given in this study.  Beta-alanine can cause a flushing/tingling 
sensation that may be uncomfortable but usually lasts less than 60 minutes. 
 
There is a possible risk of muscle strain or injury during graded exercise test 
(GXT) protocol and high-speed runs on the treadmill.  During these tests you will 
be asked to give maximal effort which may lead to some discomfort.  To reduce 
the chance of these risks, preliminary screenings (Health History Questionnaire) 
are evaluated. Physical risks will be minimized by having each testing session 
conducted by qualified investigators and all speeds will be established based on 
your initial fitness level.  All testing procedures will be done in a controlled 
manner.  All additional research staff members directly involved with testing of 
the subjects are familiar with the American College of Sports Medicine standards 
and protocols for exercise testing and emergency management.  Rise in heart rate 
and blood pressure associated with exercise may also occur.  You may also 
experience minor pain, bruising, and arm soreness from having your blood drawn.  
To minimize your risks, you blood will be drawn by an individual trained in 
phlebotomy. 
If you are a female, you must not be and should not become pregnant nor breast-feed an 
infant while on this study.  Taking the study drug(s), undergoing a particular procedure or 
treatment involved in this study while pregnant or breastfeeding may involve risks to an 
embryo, fetus or infant, including birth defects which are currently unforeseeable.  In 
order to reduce your risk of pregnancy, you or your partner should use one or more of the 
acceptable methods of birth control listed below, regularly and consistently while you are 
in this study. 
Acceptable methods of birth control (continuing throughout the study and for one month 
after the study) include: 
 
o An approved oral contraceptive (birth control pill) 
o Intra-uterine device (IUD) 
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o Hormone implants (Norplant) 
o Contraceptive injection (Depo-Provera) 
o Barrier methods (diaphragm with spermicidal gel or condoms with contraceptive 
foam) 
o Transdermal contraceptives (birth control patch) 
o Vaginal contraception ring (birth control ring) 
o Sterilization (tubal ligation, hysterectomy or vasectomy) 
 
If you become pregnant or suspect that you are pregnant you should immediately inform 
the study personnel.  If you become pregnant or suspect that you are pregnant while in 
this study, a pregnancy test will need to be done.  If pregnancy is confirmed, you will 
need to withdraw from the study.  Payment for all aspects of obstetrical, child, or related 
care will be your responsibility. 
 
You have the right to access the medical information that has been collected about you as 
a part of this research study.  However, you may not have access to this medical 
information until the entire research study has completely finished and you consent to 
this temporary restriction. 
 
Are There Benefits to Taking Part in The Study?  
If you agree to take part in this study, there is no direct medical/physical benefit to you. 
We hope that the information learned from this study will benefit other patients and 
athletes in the future. 
The possible benefits of taking part in the study are the same as receiving Beta-Alanine 
without being in the study. 
 
What About Confidentiality? 
Efforts will be made to keep your personal information confidential. You will not be 
identifiable by name or description in any reports or publications about this study. We 
cannot guarantee absolute confidentiality. Your personal information may be disclosed if 
required by law.  You will be asked to sign a separate authorization form for use or 
sharing of your protected health information. 
 
There are organizations that may inspect and/or copy your research records for quality 
assurance and data analysis. These organizations include the US Food & Drug 
Administration, the OU Health and Exercise Science Metabolic and Body Composition 
Laboratory and the OUHSC Institutional Review Board.  
What Are the Costs? 
There is no cost to you for participating in this study. 
 
Will I Be Paid For Participating in This Study? 
You will be reimbursed for your time and participation in this study in the amount of 
$40.00.  Upon full-completion of the study, you will receive a check in the amount of 
$40.00.  If you are not able to complete the entire study, the amount will be pro-rated.  
Completion of the first or second visit during pre-testing will warrant $5.00 per 
completed visit.  If the third visit of the pre-testing sessions is completed, you will 
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receive $10.00, for a total of $20.00 for completing all of pre-testing.  Post-testing 
sessions will be pro-rated in a similar manner.  Completion of visits four and five will 




What if I am Injured or Become Ill While Participating in this Study?  
In the case of injury or illness resulting from this study, emergency medical treatment is 
available.  However, you or your insurance company will be responsible for the costs of 
this treatment.  No funds have been set aside by The University of Oklahoma to 
compensate you in the event of injury. 
 
What Are My Rights As a Participant? 
Taking part in this study is voluntary.  You may choose not to participate.  Refusal to 
participate will involve no penalty or loss of benefits to which you are otherwise entitled. 
If you agree to participate and then decide against it, you can withdraw for any reason 
and leave the study at any time.  You may discontinue your participation at any time 
without penalty or loss of benefits, to which you are otherwise entitled.  Whether or not 
you participate in this study will have no affect whatsoever on your academic status in 
any of the investigators classes.  You can stop participating in this study at any time. 
However, if you decide to stop participating in the study, we encourage you to talk to the 
researcher and your regular doctor first.  
 
We will provide you with any significant new findings developed during the course of the 
research that may affect your health, welfare or willingness to continue your participation 
in this study.   
 
You have the right to access the medical information that has been collected about you as 
a part of this research study.  However, you may not have access to this medical 
information until the entire research study has completely finished and you consent to 
this temporary restriction. 
 
Whom Do I Call If I have Questions or Problems? 
If you have questions, concerns, or complaints about the study or have a research-related 
injury, contact Jeffrey R. Stout, PhD at 405-325-9023 or Abbie Smith at 515-681-5842.  
 
If you cannot reach the Investigator or wish to speak to someone other than the investigator, 
contact the OUHSC Director, Office of Human Research Participant Protection at 405-271-2045. 
For questions about your rights as a research participant, contact the OUHSC Director, 




By signing this form, you are agreeing to participate in this research study under the 
conditions described. You have not given up any of your legal rights or released any 
individual or entity from liability for negligence. You have been given an opportunity to 




I agree to participate in this study: 
 
_________________________________ _______________________ _________ 
PARTICIPANT SIGNATURE (age >18) Printed Name   Date 
(Or Legally Authorized Representative) 
_________________________________ _______________________ _________ 
SIGNATURE OF PERSON    Printed Name   Date  
OBTAINING CONSENT 
